# EDGAR Filing Document

**Accession Number:** 0001591913
**File Stem:** 0001213900-25-110820
**Filing Date:** 2025-11
**Character Count:** 199707
**Document Hash:** fd3ad1dd7e41e3b53545ef6245857539
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-110820.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001213900-25-110820

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 77

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Innovative Payment Solutions, Inc.
- **CENTRAL INDEX KEY:** 0001591913
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-CATALOG & MAIL-ORDER HOUSES [5961]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55648
- **FILM NUMBER:** 251485889

**BUSINESS ADDRESS:**
- **STREET 1:** 56B 5TH AVENUE, LOT 1 #AT
- **CITY:** CARMEL BY THE SEA
- **STATE:** CA
- **ZIP:** 93921
- **BUSINESS PHONE:** (866) 477-4729

**MAIL ADDRESS:**
- **STREET 1:** 56B 5TH AVENUE, LOT 1 #AT
- **CITY:** CARMEL BY THE SEA
- **STATE:** CA
- **ZIP:** 93921

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** QPAGOS
- **DATE OF NAME CHANGE:** 20160615

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Asiya Pearls, Inc.
- **DATE OF NAME CHANGE:** 20131113

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ____________ to ____________**

**Commission file number 000-55648**

---

| |
|:---|
| **INNOVATIVE PAYMENT SOLUTIONS, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Nevada** | **33-1230229** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **732 S 6<sup>th</sup> St. #4621, Las Vegas, Nevada** | **89101** |
| (Address of Principal Executive Office) | (Zip Code) |

---

---

| |
|:---|
| **(707) 609-4797** |
| (Registrant's telephone number, including area code) |

---

---

| |
|:---|
| **n/a** |
| (Former name, former address and former fiscal year, if changed since last report) |

---

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 14, 2025, there were 490,622,547 shares of the Company's Common Stock issued and outstanding.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Form 10-Q**

**For the Quarter Ended September 30, 2025**

**Index**

---

| | | |
|:---|:---|:---|
|  |  | **Page No.** |
| [Cautionary Note Regarding Forward-Looking Statements](#a_001) | [Cautionary Note Regarding Forward-Looking Statements](#a_001) | ii |
| [**Part I. Financial Information**](#a_002) | [**Part I. Financial Information**](#a_002) | 1 |
| Item 1. | [Financial Statements (Unaudited)](#a_003) | 1 |
|  | [Condensed Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024](#a_004) | 1 |
|  | [Condensed Statements of Operations for the three and nine months ended September 30, 2025 and 2024 (Unaudited)](#a_005) | 2 |
|  | [Condensed Statements of Changes in Stockholders' Equity for the three and nine months ended September 30, 2025 and 2024 (Unaudited)](#a_006) | 3 |
|  | [Condensed Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 (Unaudited)](#a_007) | 4 |
|  | [Notes to the Condensed Financial Statements (Unaudited)](#a_008) | 5 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_009) | 32 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#a_010) | 38 |
| Item 4. | [Controls and Procedures](#a_011) | 38 |
| **[Part II. Other Information](#a_012)** | **[Part II. Other Information](#a_012)** | 39 |
| Item 1. | [Legal Proceedings](#a_012) | 39 |
| Item 1A. | [Risk Factors](#a_014) | 41 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#a_015) | 41 |
| Item 3. | [Defaults Upon Senior Securities](#a_016) | 42 |
| Item 4. | [Mine Safety Disclosures](#a_017) | 42 |
| Item 5. | [Other Information](#a_018) | 42 |
| Item 6. | [Exhibits](#a_019) | 42 |
| [Signatures](#a_020) | [Signatures](#a_020) | 43 |

---

i

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q (this "Report") contains "forward-looking statements" (as defined in Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this Report entitled "Management's Discussion and Analysis of Financial Condition and Results of Operations." Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in this Report and in the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Form 10-K")) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

● our ability to implement our business plan, including our ability to launch and generate revenue from our IPSIPay Express joint venture or other digital payment solutions we may seek to develop or commercialize in the future;

● acceptance by the marketplace of our products and services;

● our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;

● the viability of our current intellectual property and intellectual property created in the future;

● our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;

● our ability to retain key employees and third-party service providers;

● adverse changes in general market conditions for payment solutions and other products and services we offer;

● our ability to generate cash flow and profitability and continue as a going concern;

● our future financing plans and ability to repay outstanding indebtedness; and

● our ability to adapt to changes in market conditions which could impair our operations and financial performance.

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the "Management's Discussion and Analysis of Financial Condition and Results of Operation," section contain in this Report and in the "Business," "Risk Factors" and other sections of the 2024 Form 10-K. You should thoroughly read this Report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

The forward-looking statements made in this Report relate only to events or information as of the date of this Report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this Report completely and with the understanding that our actual future results may be materially different from what we expect.

ii

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**CONDENSED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **September 30,**<br>**2025** | **December 31,**<br>**2024** |
|  | **(Unaudited)** | |
| **Assets** |  |  |
| **Current Assets** |  |  |
| &nbsp;&nbsp;&nbsp;Cash | $7045 | $526 |
| &nbsp;&nbsp;&nbsp;Other current assets | 57424 | 7894 |
| &nbsp;&nbsp;&nbsp;Notes receivable – current portion | 410786 | 371170 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Assets | 475255 | 379590 |
| **Non-current assets** |  |  |
| &nbsp;&nbsp;&nbsp;Plant and equipment | 3231 | 4858 |
| &nbsp;&nbsp;&nbsp;Equity method investment | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Non-Current Assets | 3232 | 4859 |
| **Total Assets** | $**478487** | $**384449** |
| **Liabilities and Equity (Deficit)** |  |  |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $2543058 | $2986039 |
| &nbsp;&nbsp;&nbsp;Related party payables | 7832 | - |
| &nbsp;&nbsp;&nbsp;Federal relief loans – current portion | 10497 | 8869 |
| &nbsp;&nbsp;&nbsp;Notes payable, net of unamortized discount of $942 and $89,062, respectively | 1931852 | 1669873 |
| &nbsp;&nbsp;&nbsp;Convertible debt, net of unamortized discount of $73,818 and $80,971, respectively | 5547021 | 5016205 |
| &nbsp;&nbsp;&nbsp;Convertible debt – related party | 248679 | - |
| &nbsp;&nbsp;&nbsp;Derivative liability | 45016246 | 1138204 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Liabilities | 55305185 | 10819190 |
| **Non-Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Federal relief loans | 150000 | 150000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Non-Current Liabilities | 150000 | 150000 |
| **Total Liabilities** | **55455185** | **10969190** |
| **Stockholders' (Deficit)** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $0.0001 par value, 100,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024. | - | - |
| &nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value; 1,500,000,000 shares authorized, 454,236,931 and 19,081,446 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively. | 45424 | 1908 |
| &nbsp;&nbsp;&nbsp;Additional paid-in-capital | 56110580 | 52202117 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (111132702) | (62788766) |
| &nbsp;&nbsp;&nbsp;**Total Stockholders' (deficit)** | **(54976698)** | **(10584741)** |
| **Total Liabilities and Stockholders' (Deficit)** | $**478487** | $**384449** |

---

See accompanying notes to the unaudited condensed financial statements.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Condensed Statements of Operations**

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months<br> ended**<br>**September 30,**<br>**2025** | **Three months<br> ended**<br>**September 30,**<br>**2024** | **Nine months<br> ended**<br>**September 30,**<br>**2025** | **Nine months<br> ended**<br>**September 30,**<br>**2024** |
| Net Revenue | $- | $- | $- | $- |
| Cost of Goods Sold | - | - | - | - |
| **Gross loss** | **-**  | **-**  | **-**  | **-**  |
| General and administrative | 366117 | 296438 | 791061 | 1330367 |
| Depreciation and amortization | 543 | 543 | 1627 | 1627 |
| **Total Expense** | **366660** | **296981** | **792688** | **1331994** |
| **Loss from Operations** | **(366660)** | **(296981)** | **(792688)** | **(1331994)** |
| Loss on settlement and repricing of convertible notes | 11719565 | (4541102) | (5966969) | (4643454) |
| Fair value adjustment to price protected warrants | - | (2051405) | (8250469) | (2051405) |
| Loss on disposal of assets | - | - | - | (2600) |
| Interest expense | (233609) | (152376) | (674158) | (435471) |
| Interest income | 13817 | 9740 | 39616 | 21019 |
| Amortization of debt discount | (48534) | (233948) | (227025) | (874193) |
| Derivative liability movements | (33292940) | 5538008 | (30657732) | 6461496 |
| **Loss before Income Taxes** | **(22208361)** | **(1728064)** | **(46529425)** | **(2856602)** |
| Income Taxes | - | - | - | - |
| **Net Loss after income taxes** | **(22208361)** | **(1728064)** | **(46529425)** | **(2856602)** |
| Net loss from equity method investments | - | (88) | - | (660) |
| **Net loss** | **(22208361)** | **(1728152)** | **(46529425)** | **(2857262)** |
| Deemed dividend | (34082) | (426807) | (1814511) | (426807) |
| **Net loss attributable to common stockholders** | **(22242443)** | **(2154959)** | **(48343936)** | **(3284069)** |
| **Basic and diluted loss per share** | $**(0.06)** | $**(0.15)** | $**(0.23)** | $**(0.23)** |
| &nbsp;&nbsp;&nbsp;**Weighted Average Number of Shares Outstanding – Basic and diluted** | **386602664** | **14546060** | **206881473** | **14063713** |

---

See accompanying notes to the unaudited condensed financial statements.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Condensed Statements of Changes in Stockholders' Equity (Deficit)**

(Unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Preferred<br> Stock<br> Shares** | **Amount** | **Common<br> Stock<br> Shares** | **Amount** | **Additional<br> Paid-in<br> Capital** | **Accumulated<br> Deficit** | **Total<br> Stockholders'<br> Equity<br> (Deficit)** |
| **Balance at December 31, 2024** |  | $- | 19081446 | $1908 | $52202117 | $(62788766) | $(10584741) |
| Conversion of convertible debt |  | - | 54807989 | 5481 | 331821 | - | 337302 |
| Fair value of securities anti-dilution deemed dividend |  | - |  | - | 350364 | (350364) | - |
| Fair value of warrants issued to convertible debt holders |  | - |  | - | 52735 | - | 52735 |
| Stock based compensation |  | - |  | - | 17815 | - | 17815 |
| Net loss |  | - | - | - | - | (3749821) | (3749821) |
| **Balance at March 31, 2025** |  | $**-**  | **73889435** | $**7389** | $**52954852** | $**(66888951)** | $**(13926710)** |
| Conversion of convertible debt |  | - | 246060622 | 24606 | 776287 | - | 800893 |
| Fair value of securities anti-dilution deemed dividend |  | - |  | - | 1430065 | (1430065) | - |
| Fair value of warrants issued to convertible debt holders |  | - |  | - | 52432 | - | 52432 |
| Stock based compensation |  | - |  | - | 1371 | - | 1371 |
| Net loss |  | - | - | - | - | (20571243) | (20571243) |
| **Balance at June 30, 2025** |  | $**-**  | **319950057** | $**31995** | $**55215007** | $**(88890259)** | $**(33643257)** |
| Conversion of convertible debt |  |  | 64786874 | 6479 | 549736 |  | 556215 |
| Fair value of common stock issued for services |  |  | 69500000 | 6950 | 289800 |  | 296750 |
| Fair value of securities anti-dilution deemed dividend |  |  |  |  | 34082 | (34082) |  |
| Fair value of warrants issued to convertible debt holders |  |  |  |  | 20584 |  | 20584 |
| Stock based compensation |  |  |  |  | 1371 |  | 1371 |
| Net loss |  | - | - | - | - | (22208361) | (22208361) |
| **Balance at September 30, 2025** |  | $**-**  | **454236931** | $**45424** | $**56110580** | $**(111132702)** | $**(54976698)** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Preferred<br> Stock<br> Shares** | **Amount** | **Common<br> Stock<br> Shares** | **Amount** | **Additional<br> Paid-in<br> Capital** | **Accumulated<br> Deficit** | **Total<br> Stockholders'<br> Equity<br> (Deficit)** |
| **Balance at December 31, 2023** |  | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - | 13819889 | $&nbsp;&nbsp;&nbsp;&nbsp; 1382 | $50656225 | $(58235618) | $(7578011) |
| Fair value of warrants issued to convertible debt holders |  | - |  | - | 44813 | - | 44813 |
| Fair value of warrants issued on debt extinguishment |  | - |  | - | 66047 | - | 66047 |
| Fair value of warrants issued for services |  | - |  | - | 36207 | - | 36207 |
| Stock based compensation |  | - |  | - | 94464 | - | 94464 |
| Net loss |  | - | - | - | - | (331465) | (331465) |
| **Balance at March 31, 2024** |  | $**-**  | **13819889** | $**1382** | $**50897756** | $**(58567083)** | $**(7667945)** |
| Fair value of warrants issued to convertible debt holders |  | - |  | - | 42863 | - | 42863 |
| Fair value of warrants issued on debt extinguishment |  | - |  | - | 36305 | - | 36305 |
| Fair value of warrants issued for services |  | - |  | - | 36207 | - | 36207 |
| Stock based compensation |  | - |  | - | 94464 | - | 94464 |
| Net loss |  | - | - | - | - | (797645) | (797645) |
| **Balance at June 30, 2024** |  | $**-**  | **13819889** | $**1382** | $**51107595** | $**(59364728)** | $**(8255751)** |
| Conversion of convertible debt |  |  | 2365663 | 237 | 357972 |  | 358209 |
| Fair value of securities anti-dilution deemed dividend |  |  |  |  | 426807 | (426807) |  |
| Fair value of warrants issued for services |  |  |  |  | 2943 |  | 2943 |
| Stock based compensation |  |  |  |  | 31488 |  | 31488 |
| Net loss |  | - | - | - | - | (1728152) | (1728152) |
| **Balance at September 30, 2024** |  | $**-**  | **16185552** | $**1619** | $**51926805** | $**(61519687)** | $**(9591263)** |

---

See accompanying notes to unaudited condensed financial statements.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Condensed Statements of Cash Flows**

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Nine months<br> ended**<br>**September 30,**<br>**2025** | **Nine months<br> ended**<br>**September 30,**<br>**2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| Net loss | $(46529425) | $(2857262) |
| **Adjustments to reconcile net loss to net cash used in operating activities:** |  |  |
| Derivative liability movements | 30657732 | (6461496) |
| Depreciation | 1627 | 1627 |
| Amortization of debt discount | 227025 | 874193 |
| Loss on settlement and repricing of convertible notes | 5966969 | 4643454 |
| Fair value of price protected warrants | 8250469 | 2051405 |
| Fair value of common shares issued for services | 296750 |  |
| Deemed interest income | (28846) | (19614) |
| Unrealized loss on equity method investments | - | 660 |
| Warrants issued for services | - | 75357 |
| Stock based compensation | 20557 | 220416 |
| **Changes in Assets and Liabilities** |  |  |
| Receivable from equity method investments | - | (800) |
| Other current assets | (49530) | 25024 |
| Accounts payable and accrued expenses | (15884) | 571816 |
| Related party payables | 7832 | - |
| Interest receivable | (10770) | - |
| Interest accruals | 670013 | 394374 |
| **CASH USED IN OPERATING ACTIVITIES** | **(535481)** | **(480846)** |
| **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| Investment in notes receivable | - | (288333) |
| Investment in equity method investment | - | (500) |
| **CASH USED IN INVESTING ACTIVITIES** | **-**  | **(288833)** |
| **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| Proceeds from bank overdraft |  | - |
| Proceeds from notes payable | - | 233333 |
| Proceeds from convertible notes | 542000 | 785502 |
| Repayment of convertible notes | - | (298556) |
| **NET CASH PROVIDED BY FINANCING ACTIVITIES** | **542000** | **720279** |
| **NET INCRERASE (DECREASE) IN CASH** | **6519** | **(49400)** |
| Cash and cash included in assets held for sale at the beginning of the period | 526 | 50433 |
| **CASH AT END OF PERIOD** | $**7045** | $**1033** |
| **CASH PAID FOR INTEREST AND TAXES:** |  |  |
| Cash paid for income taxes | $- | $- |
| Cash paid for interest | $4143 | $41096 |
| **NON-CASH INVESTING AND FINANCING ACTIVITIES** |  |  |
| Fair value of warrants issued with convertible notes | $125751 | $87676 |
| Conversion of convertible debt to equity | $759011 | $198716 |

---

See notes to the unaudited condensed financial statements.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **1** | **ORGANIZATION AND DESCRIPTION OF BUSINESS** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**a)** **Organizational History** 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation ("IPSI" or the "Company") (originally formed on September 23, 2013 under the name "Asiya Pearls, Inc."), entered into an Agreement and Plan of Merger (the "Qpagos Merger Agreement") with Qpagos Corporation, a Delaware corporation ("Qpagos Corporation"), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company ("Merger Sub"). Pursuant to the Qpagos Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the Qpagos "Merger"), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company's name was changed from "Asiya Pearls, Inc." to "QPAGOS".

Pursuant to the Qpagos Merger Agreement, upon consummation of the Qpagos Merger, each share of Qpagos Corporation's capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"). Additionally, pursuant to the Qpagos Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation's warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Qpagos Merger. Prior to and as a condition to the closing of the Qpagos Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Qpagos Merger, Qpagos Corporation's former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

The Qpagos Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. ("Qpagos Mexico") and Redpag Electrónicos S.A.P.I. de C.V. ("Redpag"). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor.

On June 1, 2016, the board of directors of the Company (the "Board") changed the Company's fiscal year end from October 31 to December 31.

On November 1, 2019, the Company changed its corporate name from "QPAGOS" to "Innovative Payment Solutions, Inc." Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the "Vivi Shares") of common stock of Vivi Holdings, Inc. ("Vivi. or "Vivi Holdings") pursuant to a Stock Purchase Agreement dated August 5, 2019 (the "SPA"). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company's shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

On June 21, 2021, the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. ("Frictionless"). Frictionless delivered to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enabled payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company's anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **1** | **ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**a)** **Organizational History (continued)** 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. ("Beyond Fintech"), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

On May 12, 2023, the Company entered into an Agreement with Frictionless (the "May 2023 Frictionless Agreement") to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the "Beyond Fintech Shares"); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below, the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 was impaired.

On August 30, 2023, the Company implemented a 1 for 30 reverse stock split of its Common Stock. Unless the context expressly requires otherwise, as used in this Report, all share and per share numbers reflect such reverse stock split.

On September 5, 2023, the Company's entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express LLC ("IPSIPay Express") joint venture. See note 1(b) for further information.

&nbsp;&nbsp;&nbsp;&nbsp;**b)** **Description of current business** 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Direct Payments as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate "e-wallets" that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

*IPSIPay Express*

On April 28, 2023, the Company formed a new company called IPSIPay Express. This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. ("OpenPath") and EfinityPay, LLC ("EfinityPay", and the Company, collectively with OpenPath and EfinityPay, the "Members") to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the "Operating Agreement") with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as "IPEX."

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **1** | **ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**b)** **Description of current business (continued)** 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the "IPSI Capital Contribution"). The Company was required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a "Tranche"), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay's percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023. In late 2023, the Company agreed with its joint venture partners that such investment was not required as IPEX is not operational. The need for any additional advances will be addressed with the joint venture partners once IPEX becomes operational and begins generating revenue, the Company's current equity holding in IPSIPay Express remains at 22%.

Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year Common Stock purchase warrant (the "IPEX Warrant") to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

&nbsp;&nbsp;&nbsp;&nbsp;**c)** **Merger Agreement with Business Warrior** 

Business Warrior Corporation ("Business Warrior") is a publicly listed, revenue generating fintech company that offers PayPlan, a comprehensive lending software platform that includes marketing services for lenders and businesses. We believed that a potential combination with a fintech company that generates some revenue monthly would complement the development and commercial launch of our IPSIPay Express<sup>TM</sup> products and potentially other product offerings.

 

On July 28, 2024, the Company entered into an Agreement and Plan of Merger by and among the Company, IPSI Merger Sub, Inc., a Delaware corporation and a newly formed, wholly owned subsidiary of the Company ("Merger Sub") and Business Warrior.

On January 22, 2025, the Company and Business Warrior mutually agreed to terminate the Agreement and Plan of Merger dated July 28, 2024. This decision reflects our shared understanding and agreement that discontinuing the merger is in the best interest of both parties.

&nbsp;&nbsp;&nbsp;&nbsp;**d)** **Corporate address** 

The Company terminated its lease at 56B 5<sup>th</sup> Street, Lot 1, #AT, Carmel by the Sea, California, 93921, on August 31, 2023 and no longer has access to this office.

On September 13, 2025, the Company entered into a virtual premise lease agreement with Nevada Corporate Office, LLC at its premises located at 732 S 6<sup>th</sup> Street, Las Vegas, Nevada, 89101. The lease is for a period of twelve months with a rental expense of $29 per month. This rental agreement provides the Company with a physical corporate address and access to conference and meeting rooms for an additional fee.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **2** | **ACCOUNTING POLICIES AND ESTIMATES** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**a)** **Basis of Presentation** 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three and nine months ended September 30, 2025 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Report should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2024, included in the Company's Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the "SEC") on March 31, 2025.

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. GAAP.

All amounts referred to in the notes to the unaudited condensed financial statements are in United States Dollars ($) unless stated otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;**b)** **Use of Estimates** 

The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services, debt extinguishments or compensation, convertible debt and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

&nbsp;&nbsp;&nbsp;&nbsp;**c)** **Contingencies** 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company's management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's unaudited condensed financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **2** | **ACCOUNTING POLICIES AND ESTIMATES (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**d)** **Fair Value of Financial Instruments** 

The Company adopted the guidance of Accounting Standards Codification ("ASC") 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2 - Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3 - Inputs are unobservable inputs which reflect the reporting entity's own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The carrying amounts reported in the balance sheets for cash, accounts receivable, notes receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible debt and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

ASC 825-10 "*Financial Instruments*" allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

&nbsp;&nbsp;&nbsp;&nbsp;**e)** **Risks and Uncertainties** 

The Company's operations and prospects are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. In particular, there is a risk that that IPSIPay Express business (the commercial launch of which has taken longer than originally expected) may never generate revenue for the Company. Further, the ongoing wars in Ukraine and between Israel, Hamas and more recently, Hezbollah and uncertainties regarding the global economic environment which has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company's access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company's ability to generate revenue and access usual sources of liquidity on reasonable terms.

The Company's results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **2** | **ACCOUNTING POLICIES AND ESTIMATES (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**f)** **Recent accounting pronouncements** 

 ****

The Financial Accounting Standards Board ("FASB") issued additional updates during the quarter ended September 30, 2025. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company's unaudited condensed financial statements upon adoption.

&nbsp;&nbsp;&nbsp;&nbsp;**g)** **Reporting by Segment** 

The Company adopted FASB issued ASU 2023-07, "Segment Reporting (ASC Topic 280) for the annual reporting period ended December 31, 2024. The most significant provision was for the Company to disclose significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), who is the CEO. All expense categories on the Statements of Operations are significant and there are no other significant segment expenses that would require disclosure. The Company's CODM, reviews financial information presented on an aggregated basis for the purpose of making operating decisions, allocating resources, assessing financial performance and making strategic decisions related to headcount and capital expenditures. The CODM regularly reviews net loss as reported on the Company's statements of operations. The CODM uses net loss as the measure of profit or loss to allocate resources and assess performance.

Since the Company operates as one reportable segment, all financial information required by "Segment Reporting" can be found in the accompanying financial statements. The CODM does not review segment assets at a level other than that presented in the Company's balance sheets. There are no intra-entity sales or transfers, and no significant expense categories regularly provided to the CODM beyond those disclosed in the Statements of Operations.

&nbsp;&nbsp;&nbsp;&nbsp;**h)** **Cash and Cash Equivalents** 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2025 and December 31, 2024, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2025 and December 31, 2024, the balance did not exceed federally insured limits.

&nbsp;&nbsp;&nbsp;&nbsp;**i)** **Accounts Receivable and Allowance for Doubtful Accounts** 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2025 and 2024.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **2** | **ACCOUNTING POLICIES AND ESTIMATES (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**j)** **Investments** 

The Company's non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn't result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on the balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

&nbsp;&nbsp;&nbsp;&nbsp;**k)** **Plant and Equipment** 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

---

| | |
|:---|:---|
| **Description** | **Estimated Useful Life** |
| Computer equipment | 3 years |
| Office equipment | 10 years |

---

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

&nbsp;&nbsp;&nbsp;&nbsp;**l)** **Long-Term Assets** 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **2** | **ACCOUNTING POLICIES AND ESTIMATES (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**m)** **Revenue Recognition** 

The Company's revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

The Company's revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. identify
the contract with a customer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii. identify
the performance obligations in the contract;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii. determine
the transaction price;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv. allocate
the transaction price to performance obligations in the contract; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v. recognize
revenue as the performance obligation is satisfied.

The Company had no revenues for the three and nine months ended September 30, 2025 and 2024.

&nbsp;&nbsp;&nbsp;&nbsp;**n)** **Share-Based Payment Arrangements** 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards' grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the statement of operations.

Subsequent to the Company's reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;**o)** **Derivative Liabilities** 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

&nbsp;&nbsp;&nbsp;&nbsp;**p)** **Marketing and advertising expenses** 

Marketing and advertising expenditure incurred on promoting the Company's previous products were expensed as incurred. Marketing and advertising costs amounted to $325 and $5,991 for the three months ended September 30, 2025 and 2024, respectively, and $325 and $154,864 for the nine months ended September 30, 2025 and 2024, respectively.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **2** | **ACCOUNTING POLICIES AND ESTIMATES (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**q)** **Income Taxes** 

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company's policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2025 and December 31, 2024, there have been no interest or penalties incurred on income taxes.

&nbsp;&nbsp;&nbsp;&nbsp;**r)** **Comprehensive income** 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

&nbsp;&nbsp;&nbsp;&nbsp;**s)** **Reclassification of prior year presentation** 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

---

| | |
|:---|:---|
| **3** | **LIQUIDITY MATTERS AND GOING CONCERN** |

---

The Company's financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the nine months ended September 30, 2025, the Company had a net loss of $48.3 million, after deemed dividends of $1.8 million. In connection with preparing the unaudited condensed financial statements for the nine months ended September 30, 2025, management evaluated the risks described in Note 2(e) above on the Company's business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

The accompanying financial statements for the period ended September 30, 2025 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and, ultimately, becomes profitable. Management's plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay and reduce the scope of the Company's development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

The Company has determined that there is substantial doubt about its ability to continue as a going concern.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **4** | **NOTES RECEIVABLE** |

---

On February 22, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible debt) loaned funds to Business Warrior in the principal amount of $226,190, which includes an original issue discount equal to $67,857, for net proceeds to Business Warrior of $158,333. The loan is memorialized by a secured promissory note (the "Business Warrior Note"). The Business Warrior Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The Business Warrior Note matures on the earlier to occur of December 31, 2025 and the date that Business Warrior securities are listed on a national securities exchange. The Business Warrior Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. The Company has the right to exchange the Business Warrior Note for securities issued by Business Warrior in any subsequent private placement by Business Warrior. The principal and accrued interest under Business Warrior Note is convertible into common stock of Business Warrior at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. Business Warrior's obligations under the Business Warrior Note are guaranteed by Business Warrior's subsidiaries and secured by a lien on Business Warrior's accounts receivable.

The debt discount on the Business Warrior's note is amortized as income utilizing the effective interest rate method.

Between June 19, 2024 and November 27, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible debt and notes payable) loaned additional funds to Business Warrior in the aggregate principal amount of $180,000 (the "2024 Business Warrior Notes"). The 2024 Business Warrior Notes accrues interest at 8% per annum and matured between November 1, 2024 and April 27, 2025. The 2024 Business Warrior Notes plus any accrued interest may be prepaid at any time without penalty.

We have declared the notes with maturity dates prior to the filing of these financial statements, to be in default with Business Warrior and negotiations regarding the repayment of these notes is ongoing.

Loans receivable consists of the following:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Description** | **Interest<br> Rate** | **Maturity<br> date** | **Principal** | **Accrued interest** | **Unamortized<br> debt<br> discount** | **September 30,<br> 2025<br> Amount, net** | **December 31,<br> 2024<br> Amount, net** |
| Business Warrior Corporation | 0.0% | December 31, 2025 | $226190 | $- | $(10573) | $215617 | $186771 |
|  | 8.0% | November 1, 2024 | 30000 | 3077 | - | 33077 | 31282 |
|  | 8.0% | January 1, 2025 | 35000 | 3199 | - | 38199 | 36105 |
|  | 8.0% | February 1, 2025 | 50000 | 4263 | - | 54263 | 51271 |
|  | 8.0% | February 1, 2025 | 15000 | 1266 | - | 16266 | 15368 |
|  | 8.0% | April 27, 2025 | 50000 | 3364 | - | 53364 | 50373 |
| **Total Notes receivable** |  |  | $**406190** | $**15169** | $**(10573)** | $**410786** | $**371170** |

---

Discount amortized to income as deemed interest during the three months ended September 30, 2025 and 2024 was $10,187 and $8,407, respectively, and $28,846 and $19,614 for the nine months ended September 30, 2025 and 2024, respectively.

Interest earned for the three months ended September 30, 2025 and 2024 was $3,630 and $1,333, respectively and $10,770 and $1,405 for the nine months ended September 30, 2025 and 2024, respectively.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **5** | **EQUITY METHOD INVESTMENT** |

---

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EfinityPay (see note 1(b) above). As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of September 30, 2025, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

On December 31, 2024, the company impaired the equity method investment and all receivables from the joint venture by $705,142 due to uncertainty as to the ability of the Joint venture to generate revenues during the foreseeable future.

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the equity method investments related to IPSIPay Express as of September 30, 2025 and December 31, 2024 is as follows:

---

| | | |
|:---|:---|:---|
|  | **September 30,**<br>**2025** | **December 31,**<br>**2024** |
| **Equity method Investment** |  |  |
| &nbsp;&nbsp;&nbsp;Cash contribution to IPSIPay Express | $999500 | $999500 |
| &nbsp;&nbsp;&nbsp;Fair value of warrants issued to third party joint venture partners | 108220 | 108220 |
|  | 1107720 | 1107720 |
| &nbsp;&nbsp;&nbsp;Equity loss from joint venture | (404101) | (404101) |
|  | 703619 | 703619 |
| &nbsp;&nbsp;&nbsp;Receivable from IPSIPay Express | 1524 | 1524 |
|  | 705143 | 705143 |
| &nbsp;&nbsp;&nbsp;Impairment of investment | (705142) | (705142) |
| **Equity method investment** | $**1** | $**1** |

---

The loss from equity method investments for the three and nine months ended September 30, 2025 and 2024, is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months<br> ended**<br>**September 30,**<br>**2025** | **Three months<br> ended**<br>**September 30,**<br>**2024** | **Nine months<br> ended**<br>**September 30,**<br>**2025** | **Nine months<br> ended**<br>**September 30,**<br>**2024** |
| Loss from joint venture | $- | $(88) | $- | $(660) |

---

---

| | |
|:---|:---|
| **6** | **FEDERAL RELIEF LOANS** |

---

**Small Business Administration Disaster Relief loan**

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

The company has accrued interest of $10,497 and $8,869 on this loan as of September 30, 2025 and December 31, 2024, respectively.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **7** | **NOTES PAYABLE** |

---

Notes payable consists of the following:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Description** | **Interest<br> Rate** | **Maturity<br> date** | **Principal** | **Accrued<br> Interest** | **Unamortized<br> debt<br> discount** | **September 30,<br> 2025<br> Amount, <br> net** | **December 31,<br> 2024<br> Amount, <br> net** |
| Cavalry Fund I LP | 18.0% | Matured | $482000 | $167441 | $- | $649441 | $583648 |
| Mercer Street Global Opportunity Fund, LLC | 18.0% | Matured | 482000 | 167441 | - | 649441 | 583648 |
| 2024 notes | &nbsp;&nbsp;&nbsp;&nbsp;0.0 to 18.0% | February 28, 2025 to October 10, 2025 | 577778 | 56134 | (942) | 632970 | 502577 |
| **Total notes payable** |  |  | $**1541778** | $**391016** | $**(942)** | $**1931852** | $**1669873** |

---

Interest expense totaled $61,400 and $28,489 for the three months ended September 30, 2025 and 2024, respectively, and $173,860 and $77,980 for the nine months ended September 30, 2025 and 2024, respectively.

 ****

Amortization of debt discount totaled $11,569 and $14,248 for the three months ended September 30, 2025 and 2024, respectively and $88,119 and $16,908 for the nine months ended September 30, 2025 and 2024, respectively,

 **

***Cavalry Fund I LP and Mercer Street Global Opportunity Fund, LLC***

 **

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in note 8 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month notes payable in the amount of $482,000 (the "Exchange Notes") to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes.

The Exchange Notes had a maturity date of December 30, 2023 and carried an interest rate of 10% per annum. The Company had the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue a total of 1,730,058 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024 with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The automatic extension of the maturity date may not extend past November 27, 2024, thereafter all amounts due under the note are immediately due and payable. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

With effect from November 27, 2024, the notes accrue interest at 18% per annum, the default interest rate per the note agreement.

 **

***2024 Notes***

 **

Between May 29, 2024 and November 27, 2024, the Company entered into nine Securities Purchase Agreements with four accredited investors, pursuant to which the Company issued nine notes payable (the "2024 Notes") with an aggregate principal amount of $577,778 for gross proceeds of $433,333, after taking into account an aggregate original issuance discount of $144,445.

The 2024 Notes mature between February 28, 2025 and October 10, 2025 and bear interest at rates ranging from 0.0% to 8.5% per annum.

The 2024 Notes have restrictions relating to fundamental transactions which require the approval of the note holder, in addition the note holder has an optional redemption right on subsequent transactions that may require the Company to redeem all or part of the Note, at a premium of 120% of the cash amount of the Note, at the note holder's discretion.

As of September 30, 2025, notes with a principal amount of $1,408,444 and interest thereon of $379,994 are technically in default.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **8** | **CONVERTIBLE DEBT** |

---

Convertible debt payable consists of the following:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Description** | **Interest Rate** |  | **Maturity<br> date\*\*\*** | **Principal** | **Accrued<br> Interest** | **Unamortized<br> debt<br> discount** | **September 30,<br> 2025<br> Amount, net** | **December 31,<br> 2024<br> Amount, net** |
| Cavalry Fund I LP | 18.00 | %\* | Matured | $819371 | $79501 | $- | $898872 | $836942 |
| Mercer Street Global Opportunity Fund, LLC | 18.00 | %\* | Matured | 1042701 | 112141 | - | 1154842 | 1051013 |
| Red Road Holdings Corporation | 24.98 | %\*\* | Matured | - | - | - | - | 20085 |
|  | 24.51 | %\*\* | Matured | - | - | - | - | 173798 |
| Quick Capital LLC | 11.03 | %\*\* | Matured | - | - | - | - | 64171 |
| &nbsp;&nbsp;&nbsp;2023, 2024 and 2025 convertible debt | &nbsp;&nbsp;&nbsp;&nbsp;8.00 to 12.00 | % | Matured to September 11, 2026 | 3129752 | 437373 | (73818) | 3493307 | 2870196 |
| **Total convertible debt** |  |  |  | $**4991824** | $**629015** | $**(73818)** | $**5547021** | $**5016205** |

---

\* The Cavalry Fund LLP and Mercer Street Global Opportunity Fund, LLC, notes are accruing interest at the default interest rate of 18% with effect from November 27, 2024, prior to November 27, 2024, interest was accrued at 10% per annum.

\*\* The Red Road Holdings Corporation and Quick Capital LLC, interest rates are effective interest rates as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.

\*\*\* All convertible debt is technically in default due to the default on a certain convertible note. None of the convertible debt lenders have formally declared a default to the Company, other than one investor with an aggregate balance outstanding of $19,195

Interest expense totaled $155,353 and $121,916 for the three months ended September 30, 2025 and 2024, respectively and $462,944 and $351,764 for the nine months ended September 30, 2025 and 2024, respectively.

Amortization of debt discount totaled $36,964 and $219,700 for the three months ended September 30, 2025 and 2024, respectively, and $138,905 and $857,284 for the nine months ended September 30, 2025 and 2024, respectively.

The Cavalry and Mercer convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

***Cavalry and Mercer December 2022 Note Amendment Transaction***

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an "Extension Warrant") to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for the difference in exercise price.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **8** | **CONVERTIBLE DEBT (continued)** |

---

***Cavalry and Mercer December 2022 Note Amendment Transaction (continued)***

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the "Note Amendment") pursuant to which the parties agreed to the following:

&nbsp;&nbsp;&nbsp;&nbsp;(1) The
conversion price of the Cavalry/Mercer Notes was reduced from $4.50 to $0.345 per share (such reduced conversion price being
the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a
result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 shares of Common
Stock underlying the Extension Warrants was increased to 1,304,348 shares;

&nbsp;&nbsp;&nbsp;&nbsp;(2) The
Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month notes payable in the amount of $482,000 (the
"Exchange Notes"). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have
a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but
not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue a total 1,730,058 shares of Common
Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under the
Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no
legal obligation to reserve such number of shares for future issuance;

&nbsp;&nbsp;&nbsp;&nbsp;(3) Each
of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive
any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

&nbsp;&nbsp;&nbsp;&nbsp;(4) Certain
other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants
if the price of the Common Stock is $1.80 per share or above were amended effective December 30, 2022 to reduce such forced exercise
price to $1.20 per share; and

&nbsp;&nbsp;&nbsp;&nbsp;(5) The
Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants
held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to
satisfy such registration obligation.

As a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, *Debt*, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 to $0.345 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (see note 12 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

Effective December 30, 2023 on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024 with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The automatic extension of the maturity date may not extend past November 27, 2024, thereafter all amounts due under the note are immediately due and payable. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

***Cavalry Fund LLP***

 ****

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **8** | **CONVERTIBLE DEBT (continued)** |

---

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022, additionally to December 30, 2023 and again to April 30, 2024, with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The automatic extension of the maturity date may not extend past November 27, 2024, thereafter all amounts due under the note are immediately due and payable. The Company is currently negotiating with Cavalry to place the note into forbearance, currently interest is being accrued at the default interest rate of 18% per annum in terms of the agreement.

In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company's registration obligation.

Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of principal into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.

Between September 5, 2024 and November 11, 2024, Cavalry converted an aggregate of $79,608 of principal and $88,876 of interest into 2,005,762 shares of Common Stock at a conversion price of $0.084 per share realizing a loss on conversion of $37,490. Such conversion caused a reduction in the $0.345 conversion price of the notes described above to $0.084.

Between January 14, 2025 and August 12, 2025, Cavalry converted an aggregate $49,915 of interest into 58,163,177 shares of common stock at an average conversion price of $0.00086 per share. The Company realized a loss on conversion of $162,365.

In terms of the agreement with Cavalry, the conversion price of the convertible note will be adjusted downwards on any dilutive issuances. The conversion price of the convertible debt has been adjusted to $0.0005, the lowest conversion price of conversions executed during the nine months ended September 30, 2025.

On August 13, 2025, the Company entered into an agreement to modify the conversion price of the Cavalry convertible debt from $0.0005 to a conversion price of $0.01 per share of common stock, thereby reducing the number of shares of common stock that the aggregate convertible debt at September 30, 2025 is convertible into from 1,797,744,000 to 89,887,200. This is subject to certain conditions, including i) if the shares of common stock trade above $0.04 during the period expiring on December 31, 2025, the investors may convert up to 10% of the aggregate debt outstanding, ii) if the common stock trades below $0.01 and/or the Company generates no revenue by December 31, 2025, then the conversion price reverts to the original conversion price per common stock, iii) the Company has to produce revenues of at least $250,000 prior to December 31, 2025, and iv) the Company will seek approval to increase it authorized common stock by October 31, 2025, by a number to be determined by the management of the Company, failing which the original terms of the convertible note would prevail. On October 3, 2025, the Company increased its authorized shares of common stock to 1,500,000,000 shares.

The balance of the Cavalry Note plus accrued interest at September 30, 2025 was $898,872.

***Mercer Street Global Opportunity Fund, LLC***

 ****

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022, additionally to December 30, 2023 and again to April 30, 2024, with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The automatic extension of the maturity date may not extend past November 27, 2024, thereafter all amounts due under the note are immediately due and payable. The Company is currently negotiating with Mercer to place the note into forbearance, currently interest is being accrued at the default interest rate of 18% per annum in terms of the agreement.

In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company's registration obligation.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **8** | **CONVERTIBLE DEBT (continued)** |

---

***Mercer Street Global Opportunity Fund, LLC (continued)***

Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of common stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

Between August 20, 2024 and November 11, 2024, Mercer converted an aggregate of $197,348 of interest into 2,349,380 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $89,527. Such conversion caused a reduction in the $0.345 conversion price of the notes described above to $0.084.

Between January 14, 2025 and August 12, 2025, Mercer converted an aggregate $52,548 of interest into 61,933,790 shares of common stock at an average conversion price of $0.00085 per share. The Company realized a loss on conversion of $184,992.

In terms of the agreement with Cavalry, the conversion price of the convertible note will be adjusted downwards on any dilutive issuances. The conversion price of the convertible debt has been adjusted to $0.0005, the lowest conversion price of conversions executed during the nine months ended September 30, 2025.

On August 13, 2025, the Company entered into an agreement to modify the conversion price of the Mercer convertible debt from $0.0005 to a conversion price of $0.01 per share of common stock, thereby reducing the number of shares of common stock that the aggregate convertible debt at September 30, 2025 is convertible into from 2,309,684,000 to 115,484,200 shares. This is subject to certain conditions, including i) if the shares of common stock trade above $0.04 during the period expiring on December 31, 2025, the investors may convert up to 10% of the aggregate debt outstanding, ii) if the common stock trades below $0.01 and/or the Company generates no revenue by December 31, 2025, then the conversion price reverts to the original conversion price per common stock, iii) the Company has to produce revenues of at least $250,000 prior to December 31, 2025, and iv) the Company will seek approval to increase it authorized common stock by October 31, 2025, by a number to be determined by the management of the Company, failing which the original terms of the convertible note would prevail. On October 3, 2025, the Company increased its authorized shares of common stock to 1,500,000,000 shares.

The balance of the Mercer Note plus accrued interest at September 30, 2025 was $1,154,842.

***Red Road Holdings Corporation***

 ****

● On April 2, 2024, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $70,000, after an original issue discount and fees of $18,500 in exchange for the issuance of a $88,500 Convertible Note ("RRH Note 4"), bearing interest at 15%, which interest was earned on issuance of the note, an effective interest rate of 24.98%, and matured on December 30, 2024. The RRH Note 4 had mandatory repayments of $61,065 on September 30, 2024 and $13,570 per month on October 30, 2024, November 30, 2024 and December 30, 2024. The RRH Note 4 is convertible into shares of Common Stock at a variable conversion rate of 65% of the lowest trading price ten trading days before conversion. During the quarter ended December 31, 2024, the Company repaid $88,385 of the principal and interest outstanding. The final instalment was not made and a penalty charge of 150% of the total balance outstanding, amounting to $6,695 was recorded by the Company on December 30, 2024.

 On January 7, 2025 and January 8, 2025, Red Road Holdings converted an aggregate of $20,085, into 652,654 shares of Common Stock at a weighted average conversion price of $0.0308 (conversion prices ranging from $0.0325 to $0.02782), realizing a loss on conversion of $13,363, thereby extinguishing the note.

● On June 25, 2024, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $25,080 in exchange for the issuance of a $125,080 Convertible Note ("RRH Note 5"), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 24.51%, and maturing on March 30, 2025. The RRH Note 5 has mandatory repayments of $93,498 on December 30, 2024 and $16,782 per month on January 30, 2025, February 28, 2025 and March 30, 2025. The RRH Note 5 is convertible into shares of Common Stock at a variable conversion rate of 65% of the lowest trading price ten trading days before conversion. The first instalment was not made, automatically placing the note into default, with a penalty charge of 150% of the total balance outstanding of $71,921 recorded by the Company on December 30, 2024. Between January 13, 2025 and May 8, 2025, RRH converted an aggregate of $191,772, including an aggregate penalty of $54,000 into 117,230,187 shares of common stock at a weighted average conversion price of $0.00164, realizing a loss on conversion of $116,055. On May 8, 2025, RRH entered into an assignment agreement, whereby the remaining balance of the convertible note of $77,991 was assigned to a third party, who in turn assigned a portion of the convertible note to eight parties (the "assignees"). Between May 22, 2025 and May 23, 2025, the assignees and the third party converted the remaining RRH 5 note of $77,991 into 88,626,136 shares of common stock at a conversion price of $0.00088 per share, resulting in a loss on conversion of 323,964, and thereby extinguishing the note.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **8** | **CONVERTIBLE DEBT (continued)** |

---

***Quick Capital, LLC***

 ****

● On May 28, 2024, the Company closed a transaction with Quick Capital pursuant to which the Company received net proceeds of $46,500, after an original issue discount and fees of $10,644 in exchange for the issuance of a $57,144 Convertible Note ("Quick Cap Note 2"), bearing interest at an effective interest rate of 11.03% per annum, which interest is earned on issuance of the note, and maturing on November 28, 2024. The Quick Cap Note 2 has monthly repayments of $15,429 commencing on July 28, 2024. The Note is convertible into shares of Common Stock at an adjusted conversion price of $0.084 per share, in addition, the Company issued a warrant exercisable for 178,882 shares of Common Stock at an initial exercise price of $0.345 per share. The warrant has full ratchet price protection which has resulted in the number of shares exercisable under the warrant increasing to 734,694 and the exercise price being amended to $0.084 per share. No repayments have been made on the Quick Capital Note 2 which provides for a no notice default, whereupon the note accrued penalty interest at a rate of 24% per annum on the total balance outstanding. The note holder did not apply the penalty interest to the balance outstanding. On November 28, 2024, the maturity date of the note, a penalty charge of 150% of the balance outstanding of $30,856 was recorded by the Company as additional principal outstanding. On December 6, 2024, Quick Capital converted an aggregate of $29,400, including a penalty of $1,000 into 350,000 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $280. Between January 7, 2025 and March 28, 2025, Quick Capital converted an aggregate of $71,900, including a penalty of $7,729 into 15,924,541 shares of common stock at a weighted average conversion price of $0.0045 (conversion prices ranging from $0.0325 to $0.001105), realizing a loss on conversion of $29,641, thereby extinguishing the note.

 ****

***2023, 2024 and 2025 Convertible Notes***

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors to purchase convertible notes (the "2023 Convertible Notes"), receiving an aggregate of $2,026,666 in gross proceeds from the 2023 convertible notes.

Between February 6, 2024 and October 23, 2024, the Company entered into Securities Purchase Agreements with 9 accredited investors to purchase convertible notes (the "2024 Convertible Notes"), receiving an aggregate of $575,002 in gross proceeds from the 2024 Convertible Notes.

Between January 7, 2025 and September 19, 2025, the Company entered into Securities Purchase Agreements with 4 accredited investors to purchase convertible notes (the "2025 Convertible Notes"), receiving an aggregate of $542,000 in gross proceeds from the 2025 Convertible Notes, net of original issue discount of $6,000.

On April 18, 2025, the Company entered into a debt exchange agreement with our previous CFO, Mr. Rosenblum, whereby $210,000 of accrued payroll was exchanged for a convertible note with an exercise price of $0.02 per share, maturing on January 6, 2026. The note bears interest at 8% per annum. On April 29, 2025, the board of directors amended the exercise price to $0.005 per share.

In terms of the above private placements through the issuance of :

● the 2023 Convertible Notes, the 2024 Convertible Notes and the 2025 Convertible notes; and

● five-year warrants to purchase an aggregate 5,696,586 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), associated with the 2023 Convertible Notes (the "2023 Warrants"), five year warrants to purchase an aggregate of 579,711 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), associated with the 2024 Convertible Notes (the "2024 Warrants"), and five year warrants to purchase an aggregate of 52,654,761 shares of common stock at exercise prices ranging from $0.0005 to $0.084 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), associated with the 2025 Convertible Notes (the "2025 Warrants"). Warrants exercisable for 50,000,000 shares of common stock have price protection which reduces the exercise price of the warrant for any subsequent stock issuances lower than the current exercise price.

The 2023 Convertible Notes, the 2024 Convertible Notes, and the 2025 Convertible Notes bear interest at rates ranging from 0.0% to 12.0% per annum, and are convertible into shares of common stock at a conversion price of $0.0005 to $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Convertible Notes, the 2024 Convertible Notes and the 2025 Convertible Notes may be prepaid at any time without penalty.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **8** | **CONVERTIBLE DEBT (continued)** |

---

***2023, 2024 and 2025 Convertible Notes (continued)***

 ****

The Company is under no obligation to register the shares of Common Stock underlying the 2023 Convertible Notes, the 2024 Convertible Notes, the 2025 Convertible Notes or the 2023 Warrants, the 2024 Warrants and the 2025 Warrants, for public resale.

The 2023 Convertible Notes, the 2024 Convertible Notes, the 2025 Convertible Notes and the 2023 Warrants, the 2024 Warrants and the 2025 Warrants, contain conversion limitations providing that a holder thereof may not convert or exercise such securities to the extent that, if after giving effect to such conversion or exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the "Maximum Percentage") of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

On December 14, 2023, two notes totaling $225,000 ($200,000 and $25,000, respectively) which matured on December 31, 2023 were extended for an additional 3 months to March 30, 2024. In exchange for the extension, the Company issued the note holders additional warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to the note holders additional warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as consideration for the extension, the note holders were issued additional warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share. The modification was assessed in terms of ASC 470 and determined to be a debt extinguishment, resulting in the warrant value of $66,047 being expensed as a loss on convertible debt.

The Company attempted to extend the maturity date of the convertible debt to December 31, 2025, however this was not formally agreed to and was not approved by the Board of Directors, the Company is still pursuing a global settlement with all convertible note holders and note holders, no agreement has been reached as of the date of this report.

On June 2, 2025, a 2024 convertible note holders converted principal of $2,138 and interest of $2,162, totaling $4,300 into 8,600,000 shares of common stock at a conversion price of $0.0005.

On September 30, 2025, a 2023 convertible note holder converted principal of $250,000 and interest of $40,500 into 14,525,000 shares of common stock at a conversion price of $0.02 per share.

The 2023 Convertible Notes have an aggregate amount outstanding of $2,120,843 have all matured, and are technically in default, none of the 2023 Convertible Note investors have declared a default.

The 2024 Convertible Notes have an aggregate amount outstanding of $659,881, net of unamortized debt discount of $1,394, of which convertible notes with an aggregate amount outstanding of $553,778 matured and are technically in default.

One noteholder with an aggregate amount outstanding of $19,195 declared a default, none of the other investors have declared a default, this investor has not demanded payment as yet. The Company has advanced notes receivable to Business Warrior in an aggregate principal amount of $406,190 and accrued interest thereon of $15,169. These investments were made out of proceeds received on notes payable of $338,915 and convertible debt of $139,758 in the prior year from two investors who are in control of Business Warrior. We intend to negotiate a global settlement whereby we will either collect the funds from Business Warrior or these two investors and utilize the proceeds to settle our notes payable and convertible debt with these two investors, we do not expect to incur a loss or gain on a negotiated settlement with these two investors.

The 2025 Convertible Notes have an aggregate amount outstanding of $712,583, net of unamortized debt discount of $72,424.

---

| | |
|:---|:---|
| **9** | **DERIVATIVE LIABILITY** |

---

The convertible debt and warrants issued by the Company to Cavalry, Mercer, and Quick Capital, as described in Note 8 have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible debt and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible debt using a Black-Scholes valuation model.

Between January 7, 2025 and August 12, 2025, the Company received conversion notices from Cavalry, Mercer, RRH, certain RRH Assignees, Quick Capital and Seven Knots, pursuant to which $468,511 of principal, penalty and interest was converted into an aggregate of 351,130,485 shares of common stock at a weighted average conversion price of $0.001334 (conversion prices ranging from $0.0325 to $0.0005). as a result of these conversions, all of the outstanding convertible debt and warrants of the Company that contain price based anti-dilution protection had the conversion prices of such notes and the exercise price of such warrants adjusted to $0.0005 to $0.000585 per share and certain warrants of the Company that contain "full-rachet" anti-dilution price protection had the number of shares exercisable for such warrants increased by the full ratchet provision and the conversion prices of such warrants adjusted to $0.0005 per share (the "Triggering Event").

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **9** | **DERIVATIVE LIABILITY (continued)** |

---

Convertible debt with an aggregate principal and interest balance outstanding on June 2, 2025 of $1,988,523 have such price-based anti-dilution protection. Based on the lowest conversion price in the period January 7, 2025 to September 30, 2025, as described above, the conversion price of these notes was reset to $0.0005. In addition, certain warrants exercisable for 982,029,937 shares of common stock at an exercise price of $0.001105 per share, have a full ratchet provision which results in an increase in the number of shares of Common Stock exercisable for such warrants by 1,188,256,223 to a total number of shares of Common Stock exercisable for such warrants of 2,170,286,160. In addition to this, certain warrants exercisable for 50,457,897 shares of common stock have exercise price protection which reduced the exercise price of these warrants to between $0.0005 and $0.000585 per share from exercise prices ranging from $0.005 to $0.084 per share, resulting in a decrease in potential proceeds receivable from the exercise price of such warrants by $223,558.

The value of the derivative liability related to the anti-dilution price protected convertible debt and warrants was evaluated immediately prior to the Triggering Event and immediately after the Triggering Event, resulting in an additional derivative liability of $16,925,719 on the convertible debt and $8,250,569 on the warrants.

On August 13, 2025, the Company entered into an agreement to modify the conversion price of certain notes issued to Mercer, Cavalry and affiliated entities from conversion prices ranging from $0.0005 to $0.084 per share, to a conversion price of $0.01 per share of common stock. A total of $2,009,024 of the convertible debt is subject to derivative liability, resulting in a gain on repricing of convertible debt of $11,955,877. In addition convertible debt with a fixed conversion price and not subject to derivative liability was repriced resulting in a deemed dividend expense of $33.378 and certain warrants were repriced resulting in a deemed dividend expense of $704, resulting in a total deemed dividend expense of $34,082.

The net mark-to-market movement of the derivative liability for the three months ended September 30, 2025 was a net mark-to-market debit of $33,292,940 and for the nine months ended September 30, 2025 was $30,657,632, determined by using a Black-Scholes valuation model.

The following assumptions were used in the Black-Scholes valuation model:

---

| | | |
|:---|:---|:---|
|  | **Nine months<br> ended September 30,<br> 2025** | **Year ended December 31,<br> 2024** |
| Conversion price | $0.0005 to 0.01 | $0.0364 to 0.345 |
| Risk free interest rate | 3.72 to 4.44% | 3.58 to 5.50% |
| Expected life of derivative liability | 3 to 29 months | 1 to 41 months |
| Expected volatility of underlying stock | 189.8 to 443.26% | 24.3 to 262.09% |
| Expected dividend rate | 0.0% | 0.0% |

---

The movement in derivative liability is as follows:

---

| | | |
|:---|:---|:---|
|  | **Nine months<br> ended September 30, <br> 2025** | **Year ended December 31, <br> 2024** |
| Opening balance | $1138204 | $1434196 |
| Derivative financial liability arising from convertible debt and warrants | - | 226329 |
| Derivative liability arising on repricing of convertible debt and warrants | 13220310 | 6370074 |
| Fair value adjustment to derivative liability | 30657732 | (6892395) |
| Closing balance | $**45016246** | $**1138204** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**a.** **Common Stock** 

The Company has total authorized Common Stock of 1,500,000,000 shares with a par value of $0.0001 each. The Company had 454,236,931 and 19,081,446 shares of Common Stock issued and outstanding as of September 30, 2025 and December 31, 2024, respectively.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **10** | **STOCKHOLDERS' EQUITY** |

---

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2 (see Note 12) pursuant to which $13,833 of the remaining principal, interest and late payment penalty under the RRH 2 Note was converted into 164,679 shares of Common Stock at a conversion price of $0.084 per share. As a result of the conversion of the RRH Note 2, a warrant, with full ratchet anti-dilution price protection, exercise price was reduced from $0.345 per share to $0.084 per share and the number of shares exercisable was increased from 3,145,342 shares to 12,918,370 shares, resulting in a deemed dividend charge and a credit to additional paid in capital of $426,807.

Between August 6, 2024 and September 17, 2024, in terms of conversion notices received from 4 convertible note holders, including the RRH Note 2 described above, the Company issued 2,365,663 shares of common stock for the conversion of $198,716 of convertible debt at a conversion price of $0.084 per share, realizing an aggregate loss on conversion of $159,493.

Between January 7, 2025 and September 30, 2025, in terms of conversion notices received from 5 convertible note holders, the Company issued 365,655,485 shares of common stock for the conversion of $759,011 of convertible debt at a weighted average conversion price of $0.00208 (conversion prices ranging from ($0.0325 to $0.0005) realizing an aggregate loss on conversion of $935,399.

On September 28, 2025, the Company entered into a management consulting agreement and granted 2,000,000 shares to the consultant at a fair market price of $0.0235 per share, totaling $47,000.

&nbsp;&nbsp;&nbsp;&nbsp;**b.** **Restricted stock awards** 

On August 19, 2025, The Board of Directors authorized the issue of 67,500,000 shares of common stock to various parties, including 25,000,000 shares to Mr. Corbett, the Company CEO. The fair value of the shares on the date of grant was $0.0037 per share, totaling $249,750.

A summary of restricted stock activity during the period January 1, 2025 to September 30, 2025 is as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Total<br> restricted<br> shares** | **Weighted<br> average<br> fair market<br> value per<br> share** | **Total<br> unvested<br> restricted<br> shares** | **Weighted<br> average<br> fair market<br> value per<br> share** | **Total <br> vested<br> restricted<br> shares** | **Weighted<br> average<br> fair market<br> value per share** |
| **Outstanding January 1, 2025** | 783167 | $1.5000 |  | $- | 783167 | $1.50 |
| Granted and issued | 67500000 | 0.0037 |  | - | 67500000 | 0.0037 |
| Forfeited/Cancelled | - | - |  | - | - | - |
| Vested | - | - |  | - | - | - |
| **Outstanding September 30 ,2025** | 68283167 | $0.0207 |  | $- | 68283167 | $0.0207 |

---

The restricted stock granted, issued and exercisable at September 30, 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | **Restricted Stock<br> Granted and Vested** | **Restricted Stock<br> Granted and Vested** |
|<br>**Grant date Price** | **Number Granted** | **Weighted Average<br> Fair Value per Share** |
| $0.0037 | 67500000 | 0.0037 |
| $1.4700 | 683167 | $1.4700 |
| $1.5000 | 33333 | 1.5000 |
| $1.6500 | 66667 | 1.6500 |
|  | 68283167 | $0.0207 |

---

The Company has recorded an expense of $249,750 and $0 for the three and nine months ended September 30, 2025 and 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;**c.** **Preferred Stock** 

The Company has authorized 100,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2025 and December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;**d.** **Warrants** 

On March 4, 2024, the Company entered into a Securities Purchase Agreement with an accredited investor. In terms of the Securities Purchase Agreement, the Company issued a five-year warrant to purchase an aggregate of 357,764 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as compensation for the extension, the note holders were issued warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **10** | **STOCKHOLDERS' EQUITY (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**d.** **Warrants (continued)** 

Between May 3, 2024 and May 28, 2024, the Company entered into a Securities Purchase Agreements with four accredited investors. In terms of the Securities Purchase Agreement, the Company issued five-year warrants to purchase an aggregate of 468,738 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, on June 14, 2024, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2. As a result of the conversion of the RRH Note 2, all warrants of the Company that contain price-based anti-dilution protection had the exercise price of such warrants adjusted to $0.084 per share and certain warrants of the Company that contain "full ratchet" anti-dilution price protection had the number of shares exercisable for such warrants increased by the full ratchet provision and the conversion prices of such warrants adjusted to $0.084 per share. Certain warrants exercisable for 3,145,342 shares of common stock at an exercise price of $0.345 per share, have a full ratchet provision which results in an increase in the number of shares of Common Stock exercisable for such warrants by 9,773,028 to a total number of shares of Common Stock exercisable for such warrants of 12,918,370 and a reduction in the exercise price to $0.084 per share from $0.345 per share, In addition to this, certain warrants exercisable for 457,897 shares of common stock have exercise price protection which reduced the exercise price of these warrants to $0.084 per share from $0.345 per share, resulting in a decrease in potential proceeds receivable from the exercise price of such warrants by $119,511. This resulted in a fair value adjustment charge of $2,478,211 of which $2,051,405 was recorded as a charge to the statement of comprehensive loss as it related to warrants subject to derivative liability treatment and $426,807 was recorded as a deemed dividend expense, as it related to a down round adjustment to the price of a warrant issued during the current year, which is not subject to derivative liability treatment.

On January 7, 2025 and February 20, 2025, the Company entered into a Securities Purchase Agreements with one accredited investor. In terms of the Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate of 2,654,761 shares of the Common Stock at an exercise price of $0.084 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

Between April 29, 2025 and July 24, 2025, the Company entered into Securities Purchase Agreements with two accredited investors. In terms of the Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate of 50,000,000 shares of the Common Stock at an exercise price of $0.005 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

Between January 7, 2025 and August 12, 2025, the Company received conversion notices from 5 note holders. As a result of these conversion notices, all warrants of the Company that contain price-based anti-dilution protection had the exercise price of such warrants adjusted to $0.0005 to $0.000585 per share and certain warrants of the Company that contain "full ratchet" anti-dilution price protection had the number of shares exercisable for such warrants increased by the full ratchet provision and the conversion prices of such warrants adjusted to $0.0005 per share. Certain warrants exercisable for 982,029,937 shares of common stock at an exercise price of $0.001105 per share, have a full ratchet provision which results in an increase in the number of shares of Common Stock exercisable for such warrants by 1,188,256,223 to a total number of shares of Common Stock exercisable for such warrants to 2,170,286,160 and a reduction in the exercise price to $0.0005 per share from $0.001105 per share, In addition to this, certain warrants exercisable for 50,457,897 shares of common stock have exercise price protection which reduced the exercise price of these warrants to between $0.0005 and $0.000585 from $0.001105 to $0.005 per share, resulting in a decrease in potential proceeds receivable from the exercise price of such warrants by $223,558. This resulted in a fair value adjustment charge of $9,976,484 of which $8,249,765, was recorded as a charge to the statement of comprehensive loss as it related to warrants subject to derivative liability treatment and $1,726,719 was recorded as a deemed dividend expense, as it related to a down round adjustment to the price of warrants issued during the current year, which is not subject to derivative liability treatment.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **10** | **STOCKHOLDERS' EQUITY (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**d.** **Warrants (continued)** 

The 2023, 2024 and 2025 Warrants contain exercise limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the "Maximum Percentage") of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61<sup>st</sup> day after such notice.

The fair value of the warrants granted, repriced and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

---

| | |
|:---|:---|
|  | **Nine months<br> ended <br> September 30,<br> 2025** |
| Exercise price | $0.0005 to 0.084 |
| Risk free interest rate | 3.77 to 4.46% |
| Expected life | 1 month to 5 years |
| Expected volatility of underlying stock | 183.1 to 352.45% |
| Expected dividend rate | 0% |

---

A summary of warrant activity during the period January 1, 2024 to September 30, 2025 is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Shares<br> Underlying<br> Warrants** | **Exercise<br> price per<br> share** | **Weighted<br> average<br> exercise<br> price** |
| **Outstanding January 1, 2024** | 10442093 | $0.345 – 5.625 | $0.626500 |
| Granted | 1796493 | 0.084 to 0.345 | 0.267000 |
| Increase in warrants issued due to anti-dilution price protection | 9773028 | 0.0840 | 0.084000 |
| Forfeited | - | - | - |
| Exercised | - | - | - |
| **Outstanding December 31, 2024** | 22011614 | $0.084 – 5.625 | $0.319900 |
| Granted | 52654761 | 0.005 to 0.084 | 0.00474 |
| Increase in warrants issued due to anti-dilution price protection | 2157367790 | 0.0005 | 0.00050 |
| Forfeited | (531165) | 0.0005 to 1.035 | 0.97430 |
| Exercised | - | - | - |
| **Outstanding September 30, 2025** | 2231503000 | $0.0005 – 5.625 | $0.00302 |

---

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **10** | **STOCKHOLDERS' EQUITY (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**d.** **Warrants (continued)** 

The warrants outstanding and exercisable at September 30, 2025 are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Warrants Outstanding** | **Warrants Outstanding** | **Warrants Outstanding** | **Warrants Exercisable** | **Warrants Exercisable** | **Warrants Exercisable** |
|<br>**Exercise Price\*** | **Number<br> Outstanding** | **Weighted<br> Average<br> Remaining<br> Contractual<br> life in years** | **Weighted<br> Average<br> Exercise<br> Price** | **Number<br> Exercisable** | **Weighted<br> Average<br> Exercise<br> Price** | **Weighted<br> Average<br> Remaining<br> Contractual<br> life in years** |
| $0.000500 | 2200712892 | 2.22 |  | 2200712892 |  | 2.22 |
| $0.000585 | 20000000 | 4.78 |  | 20000000 |  | 4.78 |
| $0.084000 | 2654761 | 4.33 |  | 2654761 |  | 4.33 |
| $0.345000 | 7248896 | 2.94 |  | 7248896 |  | 2.94 |
| $0.450000 | 266668 | 2.73 |  | 266668 |  | 2.73 |
| $1.500000 | 33334 | 2.87 |  | 33334 |  | 2.87 |
| $4.500000 | 505560 | 0.46 |  | 505560 |  | 0.46 |
| $5.625000 | 80889 | 0.46 |  | 80889 |  | 0.46 |
|  | 2231503000 | 2.25 | $0.00302 | 2231503000 | $0.00302 | 2.25 |

---

The warrants outstanding have an intrinsic value of $51,074,697 and $0 as of September 30, 2025 and December 31, 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;**e.** **Stock options** 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the "Plan"). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

The maximum number of securities available under the Plan is 26,667 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

On October 22, 2021, the Company established its 2021 Stock Incentive Plan ("2021 Plan"). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **10** | **STOCKHOLDERS' EQUITY (continued)** |

---

&nbsp;&nbsp;&nbsp;&nbsp;**e.** **Stock options (continued)** 

During 2024, options exercisable for 6,667 shares of Common Stock expired due to the resignation of a director whose options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

On January 7, 2025, in terms of an employment agreement entered into with Mr. Corbett, the Company awarded him ten year options exercisable for 600,000 shares of common stock at an exercise price of $0.09 per share.

On April 15, 2025, options exercisable for 333,334 shares of Common Stock expired due to the resignation of the Company's CFO whose options were not exercised in accordance with the terms allowed under the plan and were therefore cancelled.

The fair value of the options granted were determined by using a Black Scholes valuation model using the following assumptions:

---

| | |
|:---|:---|
|  | **Nine months<br> ended<br> September 30,<br> 2025** |
| Exercise price | $0.09 |
| Risk free interest rate | 4.67% |
| Expected life | Ten years |
| Expected volatility of underlying stock | 200.7% |
| Expected dividend rate | 0% |

---

A summary of option activity during the period January 1, 2024 to September 30, 2025 is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Shares<br> Underlying<br> options** | **Exercise<br> price per<br> share** | **Weighted<br> average<br> exercise<br> price** |
| **Outstanding January 1, 2024** | 1520002 | $1.20 to 12.00 | $4.46 |
| Granted | - | - | - |
| Forfeited/Cancelled | (6667) | 1.20 | 1.20 |
| Exercised | - | - | - |
| **Outstanding December 31, 2024** | 1513335 | $1.20 to 12.00 | $4.47 |
| Granted | 600000 | 0.09 | 0.09 |
| Forfeited/Cancelled | (333334) | 4.50 | 4.50 |
| Exercised | - | - | - |
| **Outstanding September 30, 2025** | 1780001 | $0.09 to 12.00 | $2.989 |

---

The options outstanding and exercisable at September 30 2025 are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Options Outstanding** | **Options Outstanding** | **Options Outstanding** | **Options Exercisable** | **Options Exercisable** | **Options Exercisable** |
|<br>**Exercise Price\*** | **Number<br> Outstanding** | **Weighted<br> Average<br> Remaining<br> Contractual<br> life in years** | **Weighted<br> Average<br> Exercise<br> Price** | **Number<br> Exercisable** | **Weighted<br> Average<br> Exercise<br> Price** | **Weighted<br> Average<br> Remaining<br> Contractual<br> life in years** |
| $0.09 | 600000 | 9.28 |  | 375000 |  | 9.28 |
| $1.20 | 13334 | 6.96 |  | 13334 |  | 6.96 |
| $4.50 | 1166667 | 6.27 |  | 1166667 |  | 6.27 |
|  | 1780001 | 7.29 | $2.989 | 1555001 | $3.408 | 7.29 |

---

The options outstanding have an intrinsic value of $0 as of September 30, 2025 and December 31, 2024.

The option expense was $1,371 and $31,488 for the three months ended September 30, 2025 and 2024, respectively and $20,557 and $220,416 for the nine months ended September 30, 2025 and 2024, respectively.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **11** | **LOSS ON SETTLEMENT AND REPRICING OF CONVERTIBLE NOTES** |

---

The loss on settlement and repricing of convertible notes consists of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months<br> ended**<br>**September 30,**<br>**2025** | **Three months<br> ended**<br>**September 30,**<br>**2024** | **Nine months<br> ended**<br>**September 30,**<br>**2025** | **Nine months<br> ended**<br>**September 30,**<br>**2024** |
| Expense on extension of maturity date of convertible notes | $- | $- | $- | $(102352) |
| Penalty on convertible debt | - | (6611) | (61729) | (6611) |
| Loss on conversion of convertible debt | (236312) | (159493) | (935399) | (159493) |
| Loss on no notice default convertible note | - | (56329) | - | (56329) |
| Gain (Loss) on repriced convertible notes | 11955877 | (4318669) | (4969841) | (4318669) |
|  | $**11719565** | $**(4541102)** | $**(5966969)** | $**(4643454)** |

---

***Expense on extension of maturity date of convertible debt***

 ****

On March 14, 2024, the Company extended the maturity date of 11 convertible notes which matured between February 13, 2024 and February 23, 2024 by six months and issued the note holders additional warrants exercisable for 387,673 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment.

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, on June 14, 2024, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment.

The debt extinguishments resulted in a charge of $36,305 and $102,352 for the three and nine months ended September 30, 2024, respectively.

***Penalty on convertible debt***

 ****

Between January 7, 2025 and September 30, 2025, $61,729 of additional conversion penalties on convertible debt conversions were charged to the Company.

***Loss on conversion of convertible debt***

 ****

Between January 7, 2025 and September 30, 2025, in terms of conversion notices received from 6 convertible note holders, the Company issued 365,655,485 shares of common stock for the conversion of $759,011 of convertible debt at a weighted average conversion price of $0.00208 (conversion prices ranging from $0.0005 to $0.0325), realizing an aggregate loss on conversion of $935,399.

***Loss on price adjustment on convertible debt and warrants***

 ****

As a result of the conversion of the convertible debt, referred to in the paragraph above, all other outstanding convertible debt of the Company that contain price-based anti-dilution protection had the conversion prices of such notes adjusted to $0.001105 per share (the "Triggering Event").

The value of the derivative liability related to the anti-dilution price protected convertible debt was evaluated immediately prior to the Triggering Event and immediately after the Triggering Event, resulting in an additional derivative liability and loss on convertible debt of $16,925,718.

On August 13, 2025, the Company entered into an agreement with Cavalry and Mercer and their affiliated entities, repricing the conversion feature of certain convertible notes from prices ranging from $0.0005 to $0.345 per share to a conversion price of $0.01 per share, resulting in a gain on repricing of convertible debt and a reduction in derivative liability of $11,955,877.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **12** | **NET LOSS PER SHARE** |

---

Basic loss per share is based on the weighted-average number of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three and nine months ended September 30, 2025 and 2024 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2025 and 2024 are as follows:

---

| | | |
|:---|:---|:---|
|  | **Nine months<br> ended<br> September 30,<br> 2025<br> (Shares)** | **Nine months<br> ended<br> September 30, <br> 2024<br> (Shares)** |
| Convertible debt | 599675944 | 38680397 |
| Stock options | 1555001 | 1513335 |
| Warrants to purchase shares of Common Stock | 2231503000 | 21721759 |
|  | 2832733945 | 61915491 |

---

---

| | |
|:---|:---|
| **13** | **RELATED PARTY TRANSACTIONS** |

---

The following transactions were entered into with related parties:

**William Corbett**

In terms of an employment agreement entered into on January 7, 2025, with Mr. Corbett, which is for a term expiring on December 31, 2025 at a base salary of $20,000 per month, Mr. Corbett was awarded ten year options exercisable for 600,000 shares of common stock at an exercise price of $0.09 per share. With the resignation of Mr. Rosenblum, disclosed below, Mr. Corbett assumed the role of Chief Executive Officer, Chief Financial Officer and President of the Company.

The option expense for options still vesting for Mr. Corbett was $1,371 and $22,196 for the three months ended September 30, 2025 and 2024, respectively and $20,557 and $155,369 for the nine months ended September 30, 2025 and 2024, respectively.

On April 18, 2025, the Company entered into a convertible note agreement, whereby $240,000 of payroll accrued to Mr. Corbett was exchanged for a convertible note, bearing interest at 8% per annum and maturing on January 6, 2026. The convertible note was convertible into shares of common stock at a conversion price of $0.02 per share. On April 29, 2025, the board of directors approved an amendment to the exercise price to $0.005 per share.

On August 19, 2025, the board of directors granted Mr. Corbett 25,000,000 shares of common stock with a fair market value of $0.0037 per share, totaling $92,500.

As of September 30, 2025 and December 31, 2024, the company owed Mr. Corbett $7,832 and $0, respectively. Mr. Corbett paid certain operating expenses on behalf of the Company.

**Richard Rosenblum**

The option expense for options still vesting for Mr. Rosenblum was $0 and $9,292 for the three months ended September 30, 2025 and 2024, respectively and $0 and $65,047 for the nine months ended September 30, 2025 and 2024, respectively.

On April 18, 2025, the Company entered into a convertible note agreement, whereby $210,000 of payroll accrued to Mr. Rosenblum was exchanged for a convertible note, bearing interest at 8% per annum and maturing on January 6, 2026. The convertible note was convertible into shares of common stock at a conversion price of $0.02 per share. On April 29, 2025, the board of directors approved an amendment to the exercise price to $0.005 per share.

Mr. Rosenblum resigned all his positions with the Company with effect from January 7, 2025.

---

| | |
|:---|:---|
| **14** | **COMMITMENTS AND CONTINGENCIES** |

---

The Company has notes payable and convertible debt, disclosed under Notes 7 and 8 above, which had and have already matured and are technically in default. Should the convertible debt not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on this convertible debt.

**INNOVATIVE PAYMENT SOLUTIONS, INC.**

**Notes to the Unaudited Condensed Financial Statements**

---

| | |
|:---|:---|
| **15** | **SUBSEQUENT EVENTS** |

---

**Conversion of convertible debt**

Between October 9, 2025 and October 15, 2025, the Company received conversion notices from convertible note holders converting an aggregate of $472,712 into 36,385,616 shares of common stock at conversion prices ranging from $0.005 per share to $0.02 per share, resulting in a loss on conversion of $423,118.

**Convertible debt funding**

On October 1, 2025, the Company entered into two convertible note agreements pursuant to which the Company issued 2 convertible promissory notes, each totaling $62,500, each with an original issue discount of $12,500, for net proceeds of $50,000 each. The notes are unsecured and mature on July 2, 2026, bearing interest at 10% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of the lesser of $0.01 or 90% of the average of the two lowest volume weighted average prices ("VWAPS") for the 20 consecutive trading days prior to conversion (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale.

On October 1, 2025, the Company entered into a securities purchase agreement pursuant to which the Company issued a convertible promissory note for $50,000 and a five year warrant exercisable for 2,500,000 shares of common stock at an exercise price of $0.04 per share. The note is unsecured and matures on September 30, 2026, bearing interest at 8% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.01 (as adjusted for stock splits, stock combinations, and similar events), unless there is an event of default, as defined in the agreement, whereby the conversion price will be 75% of the lowest volume weighted average prices for the 30 days prior to conversion. The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale. The warrants are price protected and any subsequent equity transaction at a lower exercise price will reduce the exercise price of the warrant, to that lower price.

On October 3, 2025, the Company entered into a convertible promissory note agreement for $25,000. The note is unsecured and matures on October 3, 2026, bearing interest at 8% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.01 (as adjusted for stock splits, stock combinations, and similar events). The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale.

**Temporary modification of conversion price of convertible debt**

On October 1, 2025, the Company entered into an agreement with certain convertible note holders and warrant holders whereby the Company and the convertible note holders agreed as follow:

● To cancel all warrants currently issued, if any.

● To modify the conversion price of certain convertible debt from $0.345 per share to a conversion price of $0.01 per share of common stock. This is subject to certain conditions, including i) if the shares of common stock trade above $0.04 during the period expiring on December 31, 2025, the investors may convert up to 10% of the aggregate debt outstanding, ii) if the common stock trades below $0.01 and/or the Company generates no revenue by December 31, 2025, then the conversion price reverts to the original conversion price per common stock, iii) the Company has to produce revenues of at least $250,000 prior to December 31, 2025, and iv) the Company will seek approval to increase it authorized common stock by October 31, 2025, this approval was obtained on October 3, 2025.

**Increase in authorized share capital**

On October 3, 2025, the Company filed restated articles of incorporation with the Secretary of State of the State of Nevada, increasing the authorized capital of the company to 1,600,000,000 shares, of which 1,500,000,000 are designated as common stock and 100,000,000 is designated as preferred shares. The amendment to the articles of incorporation was approved by majority written consent of the shareholders in terms of Nevada Revised Statutes and became immediately effective upon filing.

**Joint Venture Agreement**

On October 29, 2025, the Company entered into a Limited Liability Company Operating Agreement with Brant Point Solutions, LLC to form a new Delaware limited liability company, Jetties Partners, LLC (d/b/a IPSIPAY) (the "Joint Venture").

The purpose of the Joint Venture is to develop, market, distribute, and operate real-time financial technology merchant processing payment solutions branded as IPSIPay or PayzliPlus, initially targeting gaming, sportsbook, and casino entertainment markets.

The Agreement outlines the parties' respective contributions, governance structure, management rights, and other material terms relating to the operation of the Joint Venture. The Company believes that this collaboration will expand its reach within the real-time payments and gaming merchant processing industries through the integration of complementary technologies and market relationships.

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

 

*All references to "we," "us," "our" and the "Company" refer to Innovative Payment Solutions, Inc., a Delaware corporation unless the context requires otherwise.*

 

**Overview**

We are a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Direct Payments (which we call IPEX) as well as traditional credit card processing services. We have in the past (under the name IPSIPay) and may in the future develop and operate "e-wallets" that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

**Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business**

***IPSIPay Express***

 **

While we believe the IPSIPay Express opportunity has great promise, as of the date of this report, IPEX has not been launched and we have derived no revenue or cash distributions from IPSIPay Express. We expect that revenue will be generated by IPSIPay Express through fees derived from merchant processing fees, money transfer fees, and commissions on international bill payment processing. To date, our activities related to IPSIPay Express have included the following:

● Securing Banking Relationships. To engage in traditional credit card processing or the proposed IPEX account-to-account payment solution, it is necessary to work with qualified banking institutions through which transactions are processed. As of the date of this Report, such relationships are not in place.

● Assisting with Payment Logistics. We have been working with our IPSIPay Express joint venture partners to establish the systems and technology necessary to effectuate payments through IPEX. As of the date of this Report, the establishment of such systems and technology is still ongoing, which is the primary reason why IPEX has not been commercially launched to date.

● Securing Customers. Our management has also been working to secure potential customers for IPEX. These customers would include gaming and entertainment businesses.

No assurances can be given that IPSIPay Express will be successfully launched or will generate revenues or otherwise have a positive impact on our results of operations. We believe IPSIPay Express could be commercially launched and generate initial revenues during the current fiscal year, but no assurances can be provided that this will be achieved or that (i) we will be able to raise funds satisfactory to fulfill all of our capital contributions to IPSIPay Express or (ii) that we will ever receive distributions of free cash flow from IPSIPay Express. Moreover, the IPSIPay Express product offering will be targeting so-called "high risk" sectors such as online gaming and entertainment, which also carries certain risks.

***Inflation***

Macro-economic conditions could affect consumer spending adversely and consequently our future operations when we fully launch our e-wallet products commercially. The U.S. has entered a period of significant inflation, and this may impact consumer's desire to adopt our products and services and may increase our costs overall. However, as of the date of this report, we do not expect there to be any material impact on our liquidity as forecast in our business plan due to recent inflationary concerns in the U.S.

 ****

***Foreign Exchange Risks***

We intend to operate in several foreign countries. Changes and fluctuations in the foreign exchange rate between the US Dollar and other foreign currencies may in future have an effect our results of operations.

**Critical Accounting Estimates**

Preparation of our financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Financial Statements included in Part I, Item I of this Form 10-Q for further information.

The critical accounting policies that involved significant estimation included the following:

***Derivative liabilities***

We have certain short-term convertible debt and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

The derivative liability is valued using the following inputs:

● Conversion prices;

● Current market prices of our equity

● Risk free interest rates;

● Expected remaining life of the derivative liability;

● Expected volatility of the underlying stock; and expected dividend rates

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our Common Stock may result in a significant increase or decrease in the derivative liability.

**Results of Operations**

**Results of Operations for the Three Months Ended September 30, 2025 and 2024**

 ****

***Net revenue***

We had no revenues for the three months ended September 30, 2025 and 2024. We pivoted to focus our attention on the IPSIPay Express joint venture and potential payment processing opportunities to generate revenues, however there can be no guarantees that we will be successful in our endeavors.

 ****

***Cost of goods sold***

We had no cost of goods sold for the three months ended September 30, 2025 and 2024.

***General and administrative expenses***

General and administrative expenses were $366,117 and $296,438 for the three months ended September 30, 2025 and 2024, respectively, an increase of $69,679 or 23.5%. The increase is primarily due to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i) Salaries and wages were $159,709 and $140,087 for the three months ended September 30, 2025 and 2024, respectively, an increase of $19,622 or 14.0%. The increase is primarily due to the issue of 25,000,000 shares of restricted stock to our CEO with a fair market value of $92,500, offset by a decrease in payroll expense due to the resignation of our CFO during the first quarter, resulting in a saving of $54,000, the resignation of an administrative member resulting in a saving of $20,321, offset by an increase in our CEO's salary of $30,000 over the prior year, and a reduction in stock based compensation expense of $30,117 related to the amortization of stock options issued in the prior year.

ii) Consulting fees were $145,511 and $17,803 for the three months ended September 30, 2025 and 2024, respectively, an increase of $127,708 or 717.3%. The increase is primarily due to an increase in consulting fees of $10,000 due to administrative functions being performed by consultants and additional consulting fees settled by the issuance of restricted stock with a fair market value of $120,250 to consultants who have been advising the Company.

iii) Audit fees were $14,000 and $12,500 for the three months ended September 30, 2025 and 2024, an increase of $1,500 or 12.0%. The increase represents an increase in our quarterly review fees.

iv) Professional fees were $10,075 and $11,607 for the three months ended September 30, 2025 and 2024, respectively, a decrease of $1,532 or 13.2%. The decrease is primarily due to a reduction in filing fees.

v) Legal fees were $19,315 and $89,334 for the three months ended September 30, 2025 and 2024, respectively, a decrease of $70,019 or 78.4%. The decrease is primarily due to the settlement of the unfair dismissal matters which were claimed in the prior year by several individuals.

vi) Selling and marketing expenses was $325 and $5,991 for the three months ended September 30, 2025 and 2024, respectively, a decrease of $5,666 or 94.6%. Selling and marketing costs related to an endorsement deal with a celebrity ceased during the prior year.

vii) The balance of the general and administrative expenses was $17,182 and $19,116 for the three months ended September 30, 2025 and 2024, respectively, a decrease of $1,934 or 10.1 %. The decrease is made up of several individually insignificant items.

***Depreciation and amortization***

Depreciation was $543 and $543 for the three months ended September 30, 2025 and 2024. Depreciation is on small office related equipment.

***Gain (Loss) on settlement and repricing of convertible notes***

Gain on settlement and repricing of convertible notes was $11,719,565 for the three months ended September 30, 2025 and loss on settlement and repricing of convertible notes was$4,541,102 for the three months ended September 30, an increase of $16,260,667 or 358.1%. The gain on settlement and repricing of convertible notes during the current year related to; (i) a loss of $236,312 realized on conversion of certain convertible debt at prices lower than the current market price during the current period and (ii) a gain on repricing of certain convertible debt from prices ranging from $0.0005 to $0.345 per share to $0.01 per share, resulting in a gain of $11,955,877. In the prior period, the loss on settlement and repricing of convertible notes related to (i) a loss of $4,318,669 realized on an anti-dilution adjustment to the conversion feature of certain convertible notes; (ii) a loss of $56,329 realized on the conversion feature of a convertible note which through a no notice default clause, triggered a variable priced conversion liability; and (iii) a loss of $159,493 realized on conversion of certain convertible notes at prices lower than the current market price during the prior year.

***Fair value adjustment to price protected warrants***

Fair value on price protected warrants was $0 and $2,051,405 for the three months ended September 30, 2025 and 2024, respectively. During the prior year the exercise price of certain warrants were reset due to the anti-dilution price protection and in the case of certain warrants, full ratchet price protection, from an exercise price of $0.345 to $0.084. This resulted in a Black -Scholes derived valuation difference related to those certain warrants of $2,051,405.

***Interest expense***

Interest expense was $233,609 and $152,379 for the three months ended September 30, 2025 and 2024, respectively, an increase of $81,230 or 53.3%. The increase is primarily related to the contractual increase in the interest rates on several matured notes which are currently in forbearance and additional notes issued during the current period.

***Interest income***

 ****

Interest income was $13,817 and $9,740 for the three months ended September 30, 2025 and 2024, respectively, an increase of $4,077 or 41.9%. The interest income relates to funds advanced to Business Warrior prior to the cessation of our merger plans with them, we increased our investment in Business Warrior over the second half of the prior year.

***Amortization of debt discount***

Amortization of debt discount was $48,534 and $233,948 for the three months ended September 30, 2025 and 2024, respectively, a decrease of $185,414 or 79.3%. The decrease is primarily due to the full amortization of debt discount on convertible debt in the prior year. The current period funding and debt discount, and consequent amortization thereof is significantly lower than the prior period.

***Derivative liability movements***

Derivative liability movements were $(33,292,940) and $5,538,008 for the three months ended September 30, 2025 and 2024, respectively, a net movement of $38,830,948 or 701.2%. The derivative liability arose primarily due to the revaluation of certain repriced conversion features on convertible debt and warrants. The share price increased substantially during the current quarter, resulting in a significant movement in the derivative liability.

***Net loss from equity method investment***

Net loss from equity method investment was $0 and $88 for the three months ended September 30, 2025 and 2024, respectively, a decrease of $88 or 100.0%. No further expense is being incurred on the Joint Venture, in the prior period expenses were minimal and administrative in nature.

***Deemed dividend***

 ****

Deemed dividend was $34,082 and $426,807 for the three months ended September 30, 2025 and 2024, respectively, a decrease of $392,725 or 92.0%. The deemed dividend in the current and the prior period related to the repricing of warrants and convertible debt. The deemed dividend was recorded as a component of additional paid in capital.

***Net loss attributable to common stockholders***

Net loss attributable to common stockholders was $22,242,443 and $2,154,959 for the three months ended September 30, 2025 and 2024, respectively, an increase of $20,087,484 or 932.2%. The increase is primarily due to an increase in operating expenses, offset by a gain on repricing of convertible debt. Offset by the derivative liability movements, all discussed in detail above.

**Results of Operations for the Nine Months Ended September 30, 2025 and 2024**

***Net revenue***

We had no revenues for the nine months ended September 30, 2025 and 2024. We pivoted to focus our attention on the IPSIPay Express joint venture and potential payment processing opportunities to generate revenues, however there can be no guarantees that we will be successful in our endeavors.

 ****

***Cost of goods sold***

We had no cost of goods sold for the nine months ended September 30, 2025 and 2024.

***General and administrative expenses***

General and administrative expenses were $791,061 and $1,330,367 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $539,306 or 40.5%. The decrease is primarily due to the following:

i) Salaries and wages were $344,376 and $614,081 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $269,705 or 43.9%. The decrease is primarily due to the resignation of our CFO, resulting in a saving of $148,500, the resignation of our administrative personnel resulting in a saving of $40,821, offset by an increase in our CEO's salary of $30,000 over the prior period, a reduction in stock based compensation of $199,859 due to the full amortization of options in the prior period, offset by a restricted stock expense of $92,500 for stock issued to our CEO on August 19, 2025..

ii) Legal fees were $27,120 and $307,997 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $280,877 or 91.2%. The decrease is primarily due to the prior year legal fees related to unfair dismissal matters which were claimed in the prior year by several individuals.

iii) Selling and marketing expenses were $325 and $154,864 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $154,539 or 99.8%. Selling and marketing costs related to an endorsement deal with a celebrity ceased during the prior year.

iv) Consulting fees was $184,207 and $49,803 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $134,404 or 269.9%. The increase is primarily due to an increase in consulting fees of $10,000 due to administrative functions being performed by consultants and additional consulting fees settled by the issuance of restricted stock with a fair market value of $120,250 to consultants who have been advising the Company.

v) Audit fees were $123,500 and $105,000 for the nine months ended September 30, 2025 and 2024, an increase of $18,500 or 17.6%, primarily due to the timing of invoices received for services provided by our external auditors.

vi) Research and developments costs was $32,000 and $0 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $32,000 or 100.0%. The increase was due to a cost incurred on developing a new revenue source during the current period.

vii) Professional fees were $29,060 and $35,441 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $6,381 or 18.0%. The decrease is primarily due to a reduction in solicitation fees incurred in the prior year.

viii) The balance of the general and administrative expenses was $50,473 and $63,181 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $12,708 or 20.1%. The decrease is made up of several individually insignificant items.

***Depreciation***

Depreciation was $1,627 and $1,627 for the nine months ended September 30, 2025 and 2024, respectively. Depreciation is on small office related equipment.

***Loss on settlement and repricing of convertible notes***

Loss on settlement and repricing of convertible notes was $5,966,969 and $4,643,454 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $1,323,515 or 28.5%. The loss on convertible debt during the current year related to; (i) a loss of $4,969,841 realized on repriced and anti-dilution adjustment to the conversion feature of certain convertible debt; (ii) a penalty on conversion of $61,729 on conversion of convertible debt which is in default; and (iii) a loss of $935,399 realized on conversion of certain convertible debt at prices lower than the current market price during the current period. In the prior period, the loss on convertible debt related to the extension warrants issued to certain noteholders to extend the maturity date of their notes by 6 months, the value of the warrants was determined to be a debt extinguishment and were therefore expensed.

***Fair value adjustment to price protected warrants***

Fair value on price protected warrants was $8,250,469 and $2,051,405 for the nine months ended September 30, 2025 and 2024, respectively. During the current period, the exercise price of certain warrants was reset due to the anti-dilution price protection and in the case of certain warrants, full ratchet price protection, from an exercise price of $0.084 to $0.0005. This resulted in a Black -Scholes derived valuation difference related to those certain warrants. During the prior year the exercise price of certain warrants were reset due to the anti-dilution price protection and in the case of certain warrants, full ratchet price protection, from an exercise price of $0.345 to $0.084. This resulted in a Black -Scholes derived valuation difference related to those certain warrants of $2,051,405.

***Loss on disposal of assets***

Loss on disposal of assets was $0 and $2,600 for the nine months ended September 30, 2025 and 2024, respectively. The loss on disposal of assets relates to costs incurred on disposing of our kiosks in the prior year.

***Interest expense***

Interest expense was $674,158 and $435,471 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $238,687 or 54.8%. The increase is primarily related to the contractual increase in the interest rates on several matured notes which are currently in forbearance and additional notes issued during the current period.

***Interest income***

 ****

Interest income was $39,616 and $21,019 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $18,597 or 88.5%. The interest income relates to funds advanced to Business Warrior prior to the cessation of our merger plans with them, we increased our investment in Business Warrior over the second half of the prior year.

***Amortization of debt discount***

Amortization of debt discount was $227,025 and $874,193 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $647,168 or 74.0%. The decrease is primarily due to the full amortization of debt discount on convertible debt in the prior year. The current period funding and debt discount, and consequent amortization thereof, is significantly lower than the prior period.

***Derivative liability movements***

Derivative liability movements were $(30,657,732) and $6,461,496 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $37,119,228 or 574.5%. The derivative liability arose primarily due to the revaluation of certain repriced conversion features on convertible debt and warrants. The share price increased substantially during the current quarter, resulting in a significant movement in the derivative liability.

***Net loss from equity method investment***

Net loss from equity method investment was $0 and $660 for the nine months ended September 30, 2025 and 2024, respectively, a decrease of $660 or 100.0%. No further expense is being incurred on the Joint Venture, in the prior period expenses were minimal and administrative in nature.

***Deemed dividend***

 ****

Deemed dividend was $1,814,511 and $426,807 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $1,387,704 or 325.1%. The deemed dividend in the current and the prior period related to the repricing of warrants and convertible debt. The deemed dividend was recorded as a component of additional paid in capital.

***Net loss attributable to common stockholders***

Net loss was $48,343,936 and $3,284,069 for the nine months ended September 30, 2025 and 2024, respectively, an increase of $45,059,867 or 1,372.1%. The increase is primarily due to the increase in the loss on convertible debt, the increase in the fair value adjustment to price protected warrants, the negative movement in derivative liabilities and the increase in the deemed dividend expense, offset by the decrease in general and administrative expenses and the amortization of debt discount, discussed in detail above.

**Liquidity and Capital Resources**

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

We have an accumulated deficit of $111.1 million through September 30, 2025 and incurred negative cash flow from operations of $0.5 million for the nine months ended September 30, 2025. Our primary focus is on developing and marketing a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors to generate revenues. No assurances can be given, however, that such revenue generation will commence or be meaningful to us.

At September 30, 2025, we had cash of $7,045 and working capital deficit of $54.8 million, including a derivative liability of $45.0 million, after eliminating the derivative liability our working capital deficit is $9.8 million.

We used cash of $0.5 million and $0.5 million in operations for the nine months ended September 30, 2025 and 2024, respectively. We have reduced our expenditure substantially while we actively seek other revenue generating opportunities

We had no investing activities during the current period. In the prior period we had invested $0.3 million in Business Warrior while we were still pursuing merger discussions with them.

We generated cash of $0.5 million from convertible debt during the current period. In the prior period we generated $1.0 million of notes payable and convertible debt. and repaid $0.3 million of convertible debt.

At September 30, 2025, we had outstanding convertible debt, including interest thereon of $5.5 million, net of unamortized debt discount of $0.1 million and outstanding notes payable, including interest thereon of $1.9 million. The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at a rates ranging from 0% to 18% per annum. and are convertible into our common stock at conversion prices ranging from fixed conversion prices of $0.005 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), to fixed conversion prices of $0.345. Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

Given our losses and negative cash flows, we will be required to raise significant additional funds by issuing equity or equity-linked securities to progress our existing business model with IPSIPay Express. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced or discontinued operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our Company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations, accordingly, there is substantial doubt relating to our ability to continue as a going concern.

We do not have any off balance sheet financing arrangements as of the date of this Report.

**Capital Expenditures**

Our capital expenditure is dependent on our cash resources, currently we are not forecasting any additional capital expenditure for the 2025 fiscal year.

**Item 3. Quantitative and Qualitative Disclosures About Market Risks**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

**Item 4. Controls and Procedures**

(a) Evaluation of Disclosure Controls and Procedures

Pursuant to Rule 13a-15(b) under the Exchange Act, our management carried out an evaluation, with the participation of our Chief Executive Officer ("CEO") who also fulfils the role of our President and Chief Financial Officer ("CFO"), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Report. Based upon that evaluation, our CEO concluded that our disclosure controls and procedures as of September 30, 2025 are not effective due to a lack of written policies and procedures to address all material transactions and developments impacting our financial statements.

**Changes in Internal Control over Financial Reporting**

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended September 30, 2025.

 

Our management is committed to improving our controls and procedures by, among other matters, continuing to consider and adopt appropriate policies and procedures to address all material transactions and developments impacting our financial statements. However, our management does not expect that our disclosure controls and procedures and our internal control processes, even if improved, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error or fraud, if any, within our Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that the breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

**Part II. Other Information**

**Item 1. Legal Proceedings.**

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Below is a description of outstanding pending litigation matters. As also noted previously, litigation is subject to inherent uncertainties and an adverse result in the below described or other matters may arise from time to time that may harm our business. Other than as set forth below, we are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

*Voloshin, et al., v. Innovative Payment Solutions, Inc., et al.*

On October 20, 2021, a complaint was filed against our Company and certain of its officers and directors with the Occupational Safety and Health Administration of the United States Department of Labor ("OSHA"), captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleged that complainants, four former employees (or independent consultants) of our Company and one employee who was on suspension, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The complaint sought reinstatement of complainants' employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation.

In early 2022, OSHA dismissed the claims of Ms. Rey and Mr. Perez, and they appealed that decision. Prior counsel moved to dismiss the remaining claims and as of this writing OSHA took no action with respect to that motion as ultimately the former employees elected to proceed in federal court. Pursuant to agreement and stipulation, dismissal of the OSHA claims was accomplished without prejudice on November 10, 2022.

On November 7, 2022, the same five employees filed a lawsuit, not in federal court, but in the California Superior Court for the County of Los Angeles, against our Company and the same individuals against whom they had asserted their OSHA claim. The complaint asserted claims for, among other things, breach of contract, failure to pay wages and failure to reimburse expenses under the California Labor Code and asserting retaliation claims under the California Labor Code. On December 16, 2022, the same five employees filed an amended complaint dropping all defendants from the case except Mr. Corbett and our Company. The amended complaint asserts claims for violations of California Labor Code Section 1102.5; wrongful termination in violation of public policy; breach of contract; breach of covenant of good faith and fair dealing; violation of California Labor Code Section 201; waiting time penalties (Cal. Lab. Code Sections 201 & 203) and violation of California Labor Code Section 2802.

We and Mr. Corbett, the sole remaining individual defendant, through prior counsel moved to compel arbitration on February 17, 2023. As a result of that motion and a stipulated order entered by the court, all proceedings in the Superior Court were stayed.

On June 8, 2023, while our motion to compel arbitration was pending in the Superior Court three of the employees (Naum Voloshin, Alexander Voloshin, and Novikov) filed a civil action in the U.S. District Court for the Central District of California. Naum Voloshin, et al., v. Innovative Payment Solutions, Inc., Case No. CV 23-4515-JFW (PVCx), which alleges a single cause of action for retaliation in violation of The Sarbanes-Oxley Act of 2002 (the "Federal Action"). The plaintiffs in the Federal Action made no attempt to serve their complaint or to give notice to any defendant in the Federal Action until August 2023.

On August 30, 2023, the Hon. William A. Crowfoot granted our and Mr. Corbett's motion to compel arbitration, concluding that all of the claims alleged in the former employees' first amended complaint were subject to arbitration. The California Court of Appeal subsequently denied the former employees' petition for writ of mandate on November 1, 2023. On December 15, 2023, all five former employees filed a demand for arbitration. We withdrew our motion to compel appointment of an arbitrator.

Upon motion of our Company and Mr. Corbett, on January 10, 2024, the U.S. District Court for the Central District of California stayed all proceedings in the Federal Action until the arbitration is completed.

Plaintiffs Naum Voloshin, Andrey Novikov, and Alexander Voloshin asserted, in the Federal Action, that they are entitled to damages in the following amounts: Naum Voloshin: $950,000 plus an unstated amount of lost wages and emotional distress damages. The claim is premised upon Mr. Voloshin earning $15,000 per month and a claim that he was entitled to receive 333,334 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021 that he would have sold on July 1, 2021 for $2.85 per share on July 1, 2021 for $950,000. Andrey Novikov: $285,000 plus emotional distress and punitive damages. The claim is premised upon Mr. Novikov earning $15,000 per month and a claim that he was entitled to receive 100,000 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021, that he would have sold at $2.85 per share on July 1, 2021 for $285,000. Alexander Voloshin: $263,000 plus emotional distress and punitive damages. The claim is premised upon an alleged two-year contract signed in May 2021 that paid him $7,000 per month and that promised him 333,334 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021. We have not received meaningful information on the amount of the claims of the other two plaintiffs.

An arbitrator was appointed through the American Arbitration Association and the arbitrator issued a scheduling order and Notice of Hearing. The ten-day arbitration has been set for April 7-11, 2025, and April 14-18, 2025. Management continues its vigorous defense of the claims.

In mid-April 2024, the Company and Mr. Corbett changed attorneys. The Law Offices of Jeffrey B. Neustadt replaced prior counsel. Mr. Neustadt and Plaintiffs' counsel conferred and timely submitted the required joint statement on April 25, 2024.

Initial discovery was served by both sides. Documents were exchanged, and depositions proceeded for all persons.

On March 4, 2025, the Company and Mr. Corbett, entered into a settlement agreement with Naum Voloshin, Andrey Novikov, Frank Perez, Yulia Rey and Alexander Voloshin (the "Plaintiff Group"), whereby the Company agreed to pay $500,000 in settlement and full and final resolution of all claims and causes of action that the Plaintiff Group, or any member thereof, holds or has asserted (or could have asserted) against the Company and Mr. Corbett.

Within 5 days of March 4, 2025, the Company agreed to pay $100,000 (the "First Payment") and within 60 days the Company agreed to pay a further $100,000 including interest thereon at 10% per annum from March 5, 2025, and within 240 days, a final payment of $300,000, including interest thereon at 10% per annum from March 5, 2025. The initial payment of $100,000 was made on March 24, 2025. The Company has not made the second instalment as of the date of this report and has not issued the convertible notes, securing the obligations, as discussed below, as of the date of this report.

Any breach of the terms of the settlement agreement will result in a payment to the Plaintiffs of liquidated damages of $25,000 for each event of default. We are negotiating with the plaintiffs on the payment of the second instalment, and may be obligated to pay the additional $25,000 default penalty, if we are unable to agree to waive it.

In order to secure the obligations to the Plaintiff Group, the Company is to execute two convertible notes, the first note for $100,000 ("Note 1") and the second note for $300,000 ("Note 2"). Each note bears interest at the rate of 10% per annum, Note 1 has a maturity date of 60 days and Note 2, 240 days from March 5, 2025. The Notes will be convertible upon an event of default, which includes any failure to pay any of the installments. The Notes plus any accrued interest thereon, are convertible into common stock of the Company at a conversion price of $0.02 per share or the lowest conversion price of the senior secured note holders, as determined and established as the conversion price for all their notes outstanding as of March 5, 2025, if there are any limits on trading or the trading price falls below $0.01 per share, the conversion price will be discounted by a further 15%. The notes provide for certain events such as mergers and consolidations, distributions to shareholders, and stock splits and dividends.

*Minkovich v. Corbett, et al.*

On May 26, 2022, Mr. Jan Minkovich ("Minkovich") filed a lawsuit in California Superior Court in Los Angeles County (Minkovich v. Corbett, et al., CASE NO. 22CHCV00377) against our company and our Chairman and Chief Executive Officer William Corbett. The complaint asserts six causes of action for: (i) breach of contract; (ii) nonpayment of wages; (iii) waiting time penalties; (iv) failure to indemnify for alleged employee business expenses; (v) violation of Section 17200 of the California Business and Professional Code; and (vi) wrongful termination of employment in violation of public policy. Minkovich seeks $570,000 in damages, penalties, and attorneys' fees plus shares equal to five percent (5%) ownership of our company. He bases his claim in part on the unilateral expectation that he receive 2.7 million shares of the company. Assuming he is owed any shares, a claim which we dispute, after the reverse 30-1 split he would receive only 90,000 shares.

Through prior counsel, we and Mr. Corbett filed a motion to compel arbitration. The motion was denied on October 4, 2022. We and Mr. Corbett then appealed that decision to the California Court of Appeal. As a result of the appeal, the court ease was stayed until the appeal was decided. As a result of the stay, the demurrer (the equivalent of a motion to dismiss) we filed through prior counsel was not decided.

On February 27, 2024, the California Court of Appeal, Second District, reversed the Superior Court's decision denying our motion to compel arbitration. The Court of Appeal remanded the case to the Superior Court with directions to issue a new order compelling to arbitration the parties' dispute regarding the enforceability of the arbitration clause. As the prevailing parties, the Company and Mr. Corbett were awarded costs on appeal.

As expected, the plaintiff initiated arbitration before the American Arbitration Association ("AAA") based on the appellate ruling. We had expected the dispute to be resolved by the AAA arbitration process. Management had vigorously defended the claims, intends to continue to continue do so, but there is now a lull in activity as the Arbitrator is weighing several issues, the new date for arbitration was set for May 26 to 29, 2026.

Discovery has been re-opened. The parties remain engaged in informal efforts to resolve the matter but to date have been unable to agree on a resolution. Recent changes in California law may impact the Court's previous decision that sent this case to arbitration in February 2024.

**Item 1A. Risk Factors.**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

**Unregistered Sales of Equity Securities**

Between January 7, 2025 and September 30, 2025, in terms of conversion notices received from 6 convertible note holders, the Company issued 365,655,485 shares of common stock for the conversion of $759,011 of convertible debt at a weighted average conversion price of $0.00208 (conversion prices ranging from ($0.0325 to $0.0005) realizing an aggregate loss on conversion of $935,399.

Between October 1, 2025 and October 15, 2025, The Company received conversion notices from convertible note holders converting an aggregate of $472,712 into 36,385,616 shares of common stock at an average conversion price of $0.01299 per share, resulting in a loss on conversion of $423,118.

On April 29, 2025, the Company entered into Securities Purchase Agreement pursuant to which the Company issued a convertible promissory note and a warrants to one accredited investment entity for total gross proceeds of $150,000, less expenses of $6,000 for net proceeds of $144,000. The notes are unsecured, mature 12 months from issuance date and bear interest at a rate of 8% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.005 per share (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale. In terms of the Securities Purchase Agreement, the Company issued five-year warrants to purchase an aggregate of 30,000,000 shares of the Common Stock at an exercise price of $0.005 per share (as adjusted for stock splits, stock combinations, and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

On June 24, 2025, the Company entered into Securities Purchase Agreement pursuant to which the Company issued a convertible promissory note and a warrants to one accredited investment entity for total gross proceeds of $50,000. The note is unsecured, matures 12 months from issuance date and bear interest at a rate of 8% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.005 per share (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale. In terms of the Securities Purchase Agreement, the Company issued five-year warrants to purchase an aggregate of 10,000,000 shares of the Common Stock at an exercise price of $0.005 per share (as adjusted for stock splits, stock combinations, and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

On July 24, 2025, the Company entered into Securities Purchase Agreement pursuant to which the Company issued a convertible promissory note and a warrants to one accredited investment entity for total gross proceeds of $50,000. The note is unsecured, matures 12 months from issuance date and bear interest at a rate of 8% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.005 per share (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale. In terms of the Securities Purchase Agreement, the Company issued five-year warrants to purchase an aggregate of 10,000,000 shares of the Common Stock at an exercise price of $0.005 per share (as adjusted for stock splits, stock combinations, and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

On October 1, 2025, the Company entered into two convertible note agreements pursuant to which the Company issued 2 convertible promissory notes, each totaling $62,500, each with an original issue discount of $12,500, for net proceeds of $50,000 each. The notes are unsecured and mature on July 2, 2026, bearing interest at 10% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.01 or 90% of the average of the two lowest volume weighted average prices for the 20 days prior to conversion (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale.

On October 1, 2025, the Company entered into a securities purchase agreement pursuant to which the Company issued a convertible promissory note for $50,000 and a five year warrant exercisable for 2,500,000 shares of common stock at an exercise price of $0.04 per share. The note is unsecured and matures on September 30, 2026, bearing interest at 8% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.01 (as adjusted for stock splits, stock combinations, and similar events), unless there is an event of default, as defined in the agreement, whereby the conversion price will be 75% of the lowest volume weighted average prices for the 30 days prior to conversion. The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale. The warrants are price protected and any subsequent equity transaction at a lower exercise price will reduce the exercise price of the warrant, to that lower price.

On October 3, 2025, the Company entered into a convertible promissory note agreement for $25,000. The note is unsecured and matures on October 3, 2026, bearing interest at 8% per annum based on a 360 day trading-year, and are convertible into shares of common stock of the Company at a conversion price of $0.01 (as adjusted for stock splits, stock combinations, and similar events). The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale.

**Use of Proceeds from Public Offering of Common Stock**

Not applicable.

**Item 3. Defaults upon Senior Securities.**

All of the convertible debt and notes payable of the Company are technically in default, although no default has been declared, except for one investor with a balance due of $18,812. Where the notes in default provide for default penalties or interest, these have been accrued.

**Item 4. Mine Safety Disclosures.**

Not applicable.

**Item 5. Other Information.**

None.

**Item 6. Exhibits**

---

| | |
|:---|:---|
| **Exhibit No.** | **Exhibit Description** |
| 3.1 | [Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1 (File No. 333-192877) filed with the Securities and Exchange Commission on December 16, 2013)](http://www.sec.gov/Archives/edgar/data/1591913/000116552713001052/ex3-1.txt) |
| 3.2 | [Amended and Restated Bylaws of the Company (Incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 6, 2021)](http://www.sec.gov/Archives/edgar/data/1591913/000121390021024871/ea140451ex3-1_innovative.htm) |
| 3.3 | [Certificate of Amendment to Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 2, 2016)](http://www.sec.gov/Archives/edgar/data/1591913/000161577416005742/s103389_ex3-1.htm) |
| 3.4 | [Certificate of Amendment to Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 6, 2018)](http://www.sec.gov/Archives/edgar/data/1591913/000161577418001633/s109256_ex3-1.htm) |
| 3.5 | [Certificate of Amendment to the Articles of Incorporation of the Company (Name Change) (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 4, 2019)](http://www.sec.gov/Archives/edgar/data/1591913/000121390019021864/f8k110119ex3-1_innovative.htm) |
| 3.6 | [Certificate of Correction to the Certificate of Amendment to the Articles of Incorporation of the Company, dated August 24, 2023, to effect a 1-for-30 reverse stock split (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 30, 2023)](http://www.sec.gov/Archives/edgar/data/1591913/000121390023072170/ea184327ex3-1_innovative.htm) |
| 31.1\* | [Certification of William Corbett, Chief Executive Officer, President and Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)](ea026444102ex31-1_innovative.htm) |
| 32.1\* | [Certification of William Corbett, Chief Executive Officer, President and Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002](ea026444102ex32-1_innovative.htm) |
| 101.INS | Inline XBRL Instance Document.\* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.\* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.\* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.\* |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.\* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.\* |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\* |

---

\* Filed herewith

**SIGNATURES**

Pursuant to the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **INNOVATIVE PAYMENT SOLUTIONS, INC.** | **INNOVATIVE PAYMENT SOLUTIONS, INC.** |
| Date: November 14, 2025 | By: | */s/ William Corbett* |
|  |  | William Corbett |
|  |  | Principal Officer, Chief Executive Officer,<br> President & Chief Financial Officer |
|  |  | (Principal Executive Officer, Principal<br> Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE**

**15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, William Corbett, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I
have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and.

&nbsp;&nbsp;&nbsp;&nbsp;5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: November 14, 2025 | /s/ William Corbett |
|  | William Corbett |
|  | Chief Executive Officer, President and Chief Financial Officer |
|  | (Principal Executive Officer and Principal Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the "Registrant") on Form 10-Q for the quarterly period ended September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William Corbett, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

---

| | | |
|:---|:---|:---|
| Date: November 14, 2025 | By: | /s/ *William Corbett* |
|  |  | William Corbett |
|  |  | Chief Executive Officer, President and Chief Financial Officer |
|  |  | (Principal Executive Officer and Principal Accounting Officer) |

---